|
|
 |
|
| | |
| | | | | | | | | | |
family
|
|
PR:000025875 |
serpin
|
Ec-glsA1/UnMod
|
"A protein that is primarily known as an irreversible serine protease inhibitor active against S1, S8 and C14 peptidases. There are both extra- and intra-cellular serpins, which are found in all groups of organisms with the notable exception of fungi. Serpin contains a copy of the Serpin (Pfam:PF00079) domain." [InterPro:IPR000215, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000003252 |
antithrombin-III
|
SERPINC1
|
"A serpin that is a translation product of the human SERPINC1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P01008 |
antithrombin-III (human)
|
hSERPINC1
|
"An antithrombin-III that is encoded in the genome of human." [PRO:CNA, UniProtKB:P01008]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01008-1 |
antithrombin-III isoform 1 (human)
|
hSERPINC1/iso:1
|
"An antithrombin-III isoform 1 that is encoded in the genome of human." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049206 |
antithrombin-III, signal peptide removed form (human)
|
hSERPINC1/SigPep-
|
"An antithrombin-III (human) that has had the signal peptide removed. UniProtKB:P01008, 33-464." [PRO:DNx, Reactome:R-HSA-140792, Reactome:R-HSA-140807]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064430 |
antithrombin-III, signal peptide removed phosphorylated form (human)
|
hSERPINC1/SigPep-/PhosRes+
|
"An antithrombin-III (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:P01008, 33-464, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957069]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051366 |
antithrombin-III N-glycosylated 1 (human)
|
hSERPINC1/NGlyco:1
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01008-1, Asn-128, MOD:00160~GNO:G00912UN." [GlyGen:P01008-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051367 |
antithrombin-III N-glycosylated 2 (human)
|
hSERPINC1/NGlyco:2
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P01008-1, Asn-128, MOD:00160~GNO:G42358LZ." [GlyGen:P01008-1, PMID:24279413, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051368 |
antithrombin-III N-glycosylated 3 (human)
|
hSERPINC1/NGlyco:3
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-187 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01008-1, Asn-187, MOD:00160~GNO:G00912UN." [GlyGen:P01008-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051369 |
antithrombin-III N-glycosylated 4 (human)
|
hSERPINC1/NGlyco:4
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-187 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P01008-1, Asn-187, MOD:00160~GNO:G22140GZ." [GlyGen:P01008-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051370 |
antithrombin-III N-glycosylated 5 (human)
|
hSERPINC1/NGlyco:5
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-187 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P01008-1, Asn-187, MOD:00160~GNO:G88374WZ." [GlyGen:P01008-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051371 |
antithrombin-III N-glycosylated 6 (human)
|
hSERPINC1/NGlyco:6
|
"An antithrombin-III (human) that has been N-glycosylated at the residue equivalent to Asn-224 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01008-1, Asn-224, MOD:00160~GNO:G00912UN." [GlyGen:P01008-1, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051372 |
antithrombin-III O-glycosylated 1 (human)
|
hSERPINC1/OGlyco:1
|
"An antithrombin-III (human) that has been O-glycosylated at the residue equivalent to Thr-418 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01008-1, Thr-418, MOD:00005~GNO:G29068FM." [GlyGen:P01008-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051373 |
antithrombin-III O-glycosylated 2 (human)
|
hSERPINC1/OGlyco:2
|
"An antithrombin-III (human) that has been O-glycosylated at the residue equivalent to Thr-418 of the amino acid sequence represented by UniProtKB:P01008-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01008-1, Thr-418, MOD:00005~GNO:G43417UB." [GlyGen:P01008-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000064430 |
antithrombin-III, signal peptide removed phosphorylated form (human)
|
hSERPINC1/SigPep-/PhosRes+
|
"An antithrombin-III (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:P01008, 33-464, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957069]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000071477 |
antithrombin-III cysteinylated 1 (human)
|
hSERPINC1/Cyst:1
|
"An antithrombin-III (human) that has been cysteinylated on the residue at the position equivalent to Cys-160 of the amino acid sequence represented by UniProtKB:P01008. UniProtKB:P01008, Cys-160, MOD:00765." [IEDB_epitope:2127384, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P32261 |
antithrombin-III (mouse)
|
mSERPINC1
|
"An antithrombin-III that is encoded in the genome of mouse." [OMA:P32261, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P41361 |
antithrombin-III (cow)
|
cow-SERPINC1
|
"An antithrombin-III that is encoded in the genome of cow." [OMA:P41361, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q8AYE3 |
antithrombin (zebrafish)
|
z-SERPINC1
|
"An antithrombin-III that is encoded in the genome of zebrafish." [OMA:Q8AYE3, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000003253 |
antithrombin-III isoform 1
|
SERPINC1/iso:1
|
"An antithrombin-III that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01008-1 or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01008-1 |
antithrombin-III isoform 1 (human)
|
hSERPINC1/iso:1
|
"An antithrombin-III isoform 1 that is encoded in the genome of human." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000021939 |
antithrombin-III isoform 1, signal peptide removed form
|
SERPINC1/iso:1/SigPep-
|
"An antithrombin-III isoform 1 that has had the signal peptide removed." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000003255 |
antithrombin-III isoform 1, signal peptide removed glycosylated form
|
SERPINC1/iso:1/SigPep-/GlycoRes+
|
"An antithrombin-III isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000003256 |
antithrombin-III isoform 1, signal peptide removed glycosylated 1
|
SERPINC1/iso:1/SigPep-/Glyco:1
|
"An antithrombin-III isoform 1, signal peptide removed glycosylated form that has been N-glycosylated in the Asn residue within the four glycosylation patterns N{P}[ST]{P}." [PMID:17330941, UniProtKB:P01008]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000018795 |
antithrombin-III, signal peptide removed form
|
SERPINC1/SigPep-
|
"An antithrombin-III that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000021939 |
antithrombin-III isoform 1, signal peptide removed form
|
SERPINC1/iso:1/SigPep-
|
"An antithrombin-III isoform 1 that has had the signal peptide removed." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000003255 |
antithrombin-III isoform 1, signal peptide removed glycosylated form
|
SERPINC1/iso:1/SigPep-/GlycoRes+
|
"An antithrombin-III isoform 1, signal peptide removed form that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000003256 |
antithrombin-III isoform 1, signal peptide removed glycosylated 1
|
SERPINC1/iso:1/SigPep-/Glyco:1
|
"An antithrombin-III isoform 1, signal peptide removed glycosylated form that has been N-glycosylated in the Asn residue within the four glycosylation patterns N{P}[ST]{P}." [PMID:17330941, UniProtKB:P01008]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049206 |
antithrombin-III, signal peptide removed form (human)
|
hSERPINC1/SigPep-
|
"An antithrombin-III (human) that has had the signal peptide removed. UniProtKB:P01008, 33-464." [PRO:DNx, Reactome:R-HSA-140792, Reactome:R-HSA-140807]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064430 |
antithrombin-III, signal peptide removed phosphorylated form (human)
|
hSERPINC1/SigPep-/PhosRes+
|
"An antithrombin-III (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:P01008, 33-464, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957069]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000003847 |
angiotensinogen
|
AGT
|
"A serpin that is a translation product of the human AGT gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P01015 |
angiotensinogen (rat)
|
rAGT
|
"An angiotensinogen that is encoded in the genome of rat." [OMA:P01015, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01015-1 |
angiotensinogen isoform 1 (rat)
|
rAGT/iso:1
|
"An angiotensinogen isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P01019 |
angiotensinogen (human)
|
hAGT
|
"An angiotensinogen that is encoded in the genome of human." [PRO:CNA, UniProtKB:P01019]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000046285 |
angiotensinogen, signal peptide removed form (human)
|
hAGT/SigPep-
|
"An angiotensinogen (human) that has had the signal peptide removed. UniProtKB:P01019, 25-476." [PRO:DNx, Reactome:R-HSA-1998759]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051442 |
angiotensinogen N-glycosylated 1 (human)
|
hAGT/NGlyco:1
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G00912UN." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051443 |
angiotensinogen N-glycosylated 2 (human)
|
hAGT/NGlyco:2
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G08293MJ." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051444 |
angiotensinogen N-glycosylated 3 (human)
|
hAGT/NGlyco:3
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G10486CT." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051445 |
angiotensinogen N-glycosylated 4 (human)
|
hAGT/NGlyco:4
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G27947YN." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051446 |
angiotensinogen N-glycosylated 5 (human)
|
hAGT/NGlyco:5
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G40926MX." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051447 |
angiotensinogen N-glycosylated 6 (human)
|
hAGT/NGlyco:6
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G59626AS." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051448 |
angiotensinogen O-glycosylated 1 (human)
|
hAGT/OGlyco:1
|
"An angiotensinogen (human) that has been O-glycosylated at the residue equivalent to Thr-440 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01019-1, Thr-440, MOD:00005~GNO:G43417UB." [GlyGen:P01019-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P11859 |
angiotensinogen (mouse)
|
mAGT
|
"An angiotensinogen that is encoded in the genome of mouse." [OMA:P11859, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P11859-1 |
angiotensinogen isoform 1 (mouse)
|
mAGT/iso:1
|
"An angiotensinogen isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000038855 |
angiotensinogen isoform 1
|
AGT/iso:1
|
"An angiotensinogen that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P11859-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01015-1 |
angiotensinogen isoform 1 (rat)
|
rAGT/iso:1
|
"An angiotensinogen isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P11859-1 |
angiotensinogen isoform 1 (mouse)
|
mAGT/iso:1
|
"An angiotensinogen isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000018931 |
angiotensinogen, signal peptide removed form
|
AGT/SigPep-
|
"An angiotensinogen that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000018932 |
angiotensinogen proteolytic cleavage product
|
AGT/ClvPrd
|
"An angiotensinogen, signal peptide removed form that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000036008 |
angiotensin I
|
ang I
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of renin on angiotensinogen, signal peptide removed form." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000036009 |
angiotensin II
|
ang II
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000036012 |
angiotensin 1-9
|
ang 1-9
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000036009 |
angiotensin II
|
ang II
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000036012 |
angiotensin 1-9
|
ang 1-9
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000036008 |
angiotensin I
|
ang I
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of renin on angiotensinogen, signal peptide removed form." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000036009 |
angiotensin II
|
ang II
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000036012 |
angiotensin 1-9
|
ang 1-9
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000046285 |
angiotensinogen, signal peptide removed form (human)
|
hAGT/SigPep-
|
"An angiotensinogen (human) that has had the signal peptide removed. UniProtKB:P01019, 25-476." [PRO:DNx, Reactome:R-HSA-1998759]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014678 |
alpha-1-antitrypsin
|
SERPINA1
|
"A serpin that is a translation product of the human SERPINA1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P01009 |
alpha-1-antitrypsin (human)
|
hSERPINA1
|
"An alpha-1-antitrypsin that is encoded in the genome of human." [PRO:CNA, UniProtKB:P01009]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01009-1 |
alpha-1-antitrypsin isoform h1 (human)
|
hSERPINA1/iso:h1
|
"An alpha-1-antitrypsin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01009-1." [PRO:DNx, UniProtKB:P01009]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01009-2 |
alpha-1-antitrypsin isoform h2 (human)
|
hSERPINA1/iso:h2
|
"An alpha-1-antitrypsin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01009-2." [PRO:DNx, UniProtKB:P01009]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01009-3 |
alpha-1-antitrypsin isoform h3 (human)
|
hSERPINA1/iso:h3
|
"An alpha-1-antitrypsin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01009-3." [PRO:DNx, UniProtKB:P01009]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049204 |
alpha-1-antitrypsin, signal peptide removed form (human)
|
hSERPINA1/SigPep-
|
"An alpha-1-antitrypsin (human) that has had the signal peptide removed. UniProtKB:P01009, 25-418." [PRO:DNx, Reactome:R-HSA-141755, Reactome:R-HSA-141757]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060456 |
alpha-1-antitrypsin, signal peptide removed phosphorylated form (human)
|
hSERPINA1/SigPep-/PhosRes+
|
"An alpha-1-antitrypsin (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. Example: UniProtKB:P01009-1, 25-418, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957062]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064737 |
alpha-1-antitrypsin, signal peptide removed N-glycosylasparagine form (human)
|
hSERPINA1/SigPep-/NGlycoAsn+
|
"An alpha-1-antitrypsin (human) that has had the signal peptide removed and that includes at least one N-glycosylated asparagine. Example: UniProtKB:P01009-1, 25-418, MOD:00160." [PRO:DNx, Reactome:R-HSA-5689435, Reactome:R-HSA-5689731, Reactome:R-HSA-5689734]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051374 |
alpha-1-antitrypsin N-glycosylated 1 (human)
|
hSERPINA1/NGlyco:1
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G00912UN." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051375 |
alpha-1-antitrypsin N-glycosylated 2 (human)
|
hSERPINA1/NGlyco:2
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G22140GZ." [GlyGen:P01009-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051376 |
alpha-1-antitrypsin N-glycosylated 3 (human)
|
hSERPINA1/NGlyco:3
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G36131WL. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G36131WL." [GlyGen:P01009-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051377 |
alpha-1-antitrypsin N-glycosylated 4 (human)
|
hSERPINA1/NGlyco:4
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G36191CD. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G36191CD." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051378 |
alpha-1-antitrypsin N-glycosylated 5 (human)
|
hSERPINA1/NGlyco:5
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G78059CC." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051379 |
alpha-1-antitrypsin N-glycosylated 6 (human)
|
hSERPINA1/NGlyco:6
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G84467IZ." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051380 |
alpha-1-antitrypsin N-glycosylated 7 (human)
|
hSERPINA1/NGlyco:7
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-107 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G92821YI. Example: UniProtKB:P01009-1, Asn-107, MOD:00160~GNO:G92821YI." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051381 |
alpha-1-antitrypsin N-glycosylated 8 (human)
|
hSERPINA1/NGlyco:8
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G00912UN." [GlyGen:P01009-1, PMID:22171320, PMID:24841998, PMID:26791533, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051382 |
alpha-1-antitrypsin N-glycosylated 9 (human)
|
hSERPINA1/NGlyco:9
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G06247RL." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051383 |
alpha-1-antitrypsin N-glycosylated 10 (human)
|
hSERPINA1/NGlyco:10
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G08293MJ." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051384 |
alpha-1-antitrypsin N-glycosylated 11 (human)
|
hSERPINA1/NGlyco:11
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G10486CT." [GlyGen:P01009-1, PMID:22171320, PMID:24841998, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051385 |
alpha-1-antitrypsin N-glycosylated 12 (human)
|
hSERPINA1/NGlyco:12
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G22140GZ." [GlyGen:P01009-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051386 |
alpha-1-antitrypsin N-glycosylated 13 (human)
|
hSERPINA1/NGlyco:13
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G27947YN." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051387 |
alpha-1-antitrypsin N-glycosylated 14 (human)
|
hSERPINA1/NGlyco:14
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G36191CD. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G36191CD." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051388 |
alpha-1-antitrypsin N-glycosylated 15 (human)
|
hSERPINA1/NGlyco:15
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G42358LZ." [GlyGen:P01009-1, PMID:24279413, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051389 |
alpha-1-antitrypsin N-glycosylated 16 (human)
|
hSERPINA1/NGlyco:16
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G45504EY. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G45504EY." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051390 |
alpha-1-antitrypsin N-glycosylated 17 (human)
|
hSERPINA1/NGlyco:17
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G59626AS." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051391 |
alpha-1-antitrypsin N-glycosylated 18 (human)
|
hSERPINA1/NGlyco:18
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G78059CC." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051392 |
alpha-1-antitrypsin N-glycosylated 19 (human)
|
hSERPINA1/NGlyco:19
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G84467IZ." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051393 |
alpha-1-antitrypsin N-glycosylated 20 (human)
|
hSERPINA1/NGlyco:20
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G88374WZ." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051394 |
alpha-1-antitrypsin N-glycosylated 21 (human)
|
hSERPINA1/NGlyco:21
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G92821YI. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G92821YI." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051395 |
alpha-1-antitrypsin N-glycosylated 22 (human)
|
hSERPINA1/NGlyco:22
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01009-1, Asn-271, MOD:00160~GNO:G94917XT." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051396 |
alpha-1-antitrypsin N-glycosylated 23 (human)
|
hSERPINA1/NGlyco:23
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-70 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01009-1, Asn-70, MOD:00160~GNO:G00912UN." [GlyGen:P01009-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051397 |
alpha-1-antitrypsin N-glycosylated 24 (human)
|
hSERPINA1/NGlyco:24
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-70 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P01009-1, Asn-70, MOD:00160~GNO:G10486CT." [GlyGen:P01009-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051398 |
alpha-1-antitrypsin N-glycosylated 25 (human)
|
hSERPINA1/NGlyco:25
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-70 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P01009-1, Asn-70, MOD:00160~GNO:G22140GZ." [GlyGen:P01009-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051399 |
alpha-1-antitrypsin N-glycosylated 26 (human)
|
hSERPINA1/NGlyco:26
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-70 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G36191CD. Example: UniProtKB:P01009-1, Asn-70, MOD:00160~GNO:G36191CD." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051400 |
alpha-1-antitrypsin N-glycosylated 27 (human)
|
hSERPINA1/NGlyco:27
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-70 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P01009-1, Asn-70, MOD:00160~GNO:G78059CC." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051401 |
alpha-1-antitrypsin N-glycosylated 28 (human)
|
hSERPINA1/NGlyco:28
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-70 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P01009-1, Asn-70, MOD:00160~GNO:G84467IZ." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051402 |
alpha-1-antitrypsin N-glycosylated 29 (human)
|
hSERPINA1/NGlyco:29
|
"An alpha-1-antitrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-70 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan structure is represented by GlyTouCan:G92821YI. Example: UniProtKB:P01009-1, Asn-70, MOD:00160~GNO:G92821YI." [GlyGen:P01009-1, PMID:6966283, PMID:8390218, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051403 |
alpha-1-antitrypsin O-glycosylated 1 (human)
|
hSERPINA1/OGlyco:1
|
"An alpha-1-antitrypsin (human) that has been O-glycosylated at the residue equivalent to Thr-109 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01009-1, Thr-109, MOD:00005~GNO:G43417UB." [GlyGen:P01009-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051404 |
alpha-1-antitrypsin O-glycosylated 2 (human)
|
hSERPINA1/OGlyco:2
|
"An alpha-1-antitrypsin (human) that has been O-glycosylated at the residue equivalent to Thr-168 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01009-1, Thr-168, MOD:00005~GNO:G43417UB." [GlyGen:P01009-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051405 |
alpha-1-antitrypsin O-glycosylated 3 (human)
|
hSERPINA1/OGlyco:3
|
"An alpha-1-antitrypsin (human) that has been O-glycosylated at the residue equivalent to Thr-35 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01009-1, Thr-35, MOD:00005~GNO:G29068FM." [GlyGen:P01009-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051406 |
alpha-1-antitrypsin O-glycosylated 4 (human)
|
hSERPINA1/OGlyco:4
|
"An alpha-1-antitrypsin (human) that has been O-glycosylated at the residue equivalent to Thr-35 of the amino acid sequence represented by UniProtKB:P01009-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01009-1, Thr-35, MOD:00005~GNO:G43417UB." [GlyGen:P01009-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000060456 |
alpha-1-antitrypsin, signal peptide removed phosphorylated form (human)
|
hSERPINA1/SigPep-/PhosRes+
|
"An alpha-1-antitrypsin (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. Example: UniProtKB:P01009-1, 25-418, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957062]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000064737 |
alpha-1-antitrypsin, signal peptide removed N-glycosylasparagine form (human)
|
hSERPINA1/SigPep-/NGlycoAsn+
|
"An alpha-1-antitrypsin (human) that has had the signal peptide removed and that includes at least one N-glycosylated asparagine. Example: UniProtKB:P01009-1, 25-418, MOD:00160." [PRO:DNx, Reactome:R-HSA-5689435, Reactome:R-HSA-5689731, Reactome:R-HSA-5689734]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000066669 |
alpha-1-antitrypsin methylated 1 (human)
|
hSERPINA1/Me:1
|
"An alpha-1-antitrypsin (human) that has been methylated on the residue at the position equivalent to Cys-256 of the amino acid sequence represented by UniProtKB:P01009-1. Example: UniProtKB:P01009-1, Cys-256, MOD:00660." [IEDB_epitope:1042822, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P17475 |
alpha-1-antiproteinase (rat)
|
rSERPINA1
|
"An alpha-1-antitrypsin that is encoded in the genome of rat." [OMA:P17475, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P34955 |
alpha-1-antiproteinase (cow)
|
cow-SERPINA1
|
"An alpha-1-antitrypsin that is encoded in the genome of cow." [OMA:P34955, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021415 |
alpha-1-antitrypsin, signal peptide removed form
|
SERPINA1/SigPep-
|
"An alpha-1-antitrypsin that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049204 |
alpha-1-antitrypsin, signal peptide removed form (human)
|
hSERPINA1/SigPep-
|
"An alpha-1-antitrypsin (human) that has had the signal peptide removed. UniProtKB:P01009, 25-418." [PRO:DNx, Reactome:R-HSA-141755, Reactome:R-HSA-141757]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060456 |
alpha-1-antitrypsin, signal peptide removed phosphorylated form (human)
|
hSERPINA1/SigPep-/PhosRes+
|
"An alpha-1-antitrypsin (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. Example: UniProtKB:P01009-1, 25-418, MOD:00696." [PRO:DNx, Reactome:R-HSA-8957062]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064737 |
alpha-1-antitrypsin, signal peptide removed N-glycosylasparagine form (human)
|
hSERPINA1/SigPep-/NGlycoAsn+
|
"An alpha-1-antitrypsin (human) that has had the signal peptide removed and that includes at least one N-glycosylated asparagine. Example: UniProtKB:P01009-1, 25-418, MOD:00160." [PRO:DNx, Reactome:R-HSA-5689435, Reactome:R-HSA-5689731, Reactome:R-HSA-5689734]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021416 |
alpha-1-antitrypsin proteolytic cleavage product
|
SERPINA1/ClvPrd
|
"An alpha-1-antitrypsin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014679 |
protein Z-dependent protease inhibitor
|
SERPINA10
|
"A serpin that is a translation product of the human SERPINA10 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q62975 |
protein Z-dependent protease inhibitor (rat)
|
rSERPINA10
|
"A protein Z-dependent protease inhibitor that is encoded in the genome of rat." [OMA:Q62975, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q8R121 |
protein Z-dependent protease inhibitor (mouse)
|
mSERPINA10
|
"A protein Z-dependent protease inhibitor that is encoded in the genome of mouse." [OMA:Q8R121, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q8R121-1 |
protein Z-dependent protease inhibitor isoform m1 (mouse)
|
mSERPINA10/iso:m1
|
"A protein Z-dependent protease inhibitor (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8R121-1." [PRO:DNx, UniProtKB:Q8R121]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q8R121-2 |
protein Z-dependent protease inhibitor isoform m2 (mouse)
|
mSERPINA10/iso:m2
|
"A protein Z-dependent protease inhibitor (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8R121-2." [PRO:DNx, UniProtKB:Q8R121]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9UK55 |
protein Z-dependent protease inhibitor (human)
|
hSERPINA10
|
"A protein Z-dependent protease inhibitor that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q9UK55]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000058264 |
protein Z-dependent protease inhibitor N-glycosylated 1 (human)
|
hSERPINA10/NGlyco:1
|
"A protein Z-dependent protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:Q9UK55-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:Q9UK55-1, Asn-180, MOD:00160~GNO:G06247RL." [GlyGen:Q9UK55-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000058265 |
protein Z-dependent protease inhibitor N-glycosylated 2 (human)
|
hSERPINA10/NGlyco:2
|
"A protein Z-dependent protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-295 of the amino acid sequence represented by UniProtKB:Q9UK55-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:Q9UK55-1, Asn-295, MOD:00160~GNO:G00912UN." [GlyGen:Q9UK55-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000062701 |
protein Z-dependent protease inhibitor, signal peptide removed form (human)
|
hSERPINA10/SigPep-
|
"A protein Z-dependent protease inhibitor (human) that has had the signal peptide removed. UniProtKB:Q9UK55, 22-444." [PRO:DNx, Reactome:R-HSA-8956739]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064591 |
protein Z-dependent protease inhibitor, signal peptide removed phosphorylated form (human)
|
hSERPINA10/SigPep-/PhosRes+
|
"A protein Z-dependent protease inhibitor (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:Q9UK55, 22-444, MOD:00696." [PRO:DNx, Reactome:R-HSA-8956990]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000064591 |
protein Z-dependent protease inhibitor, signal peptide removed phosphorylated form (human)
|
hSERPINA10/SigPep-/PhosRes+
|
"A protein Z-dependent protease inhibitor (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:Q9UK55, 22-444, MOD:00696." [PRO:DNx, Reactome:R-HSA-8956990]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021418 |
protein Z-dependent protease inhibitor, signal peptide removed form
|
SERPINA10/SigPep-
|
"A protein Z-dependent protease inhibitor that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000062701 |
protein Z-dependent protease inhibitor, signal peptide removed form (human)
|
hSERPINA10/SigPep-
|
"A protein Z-dependent protease inhibitor (human) that has had the signal peptide removed. UniProtKB:Q9UK55, 22-444." [PRO:DNx, Reactome:R-HSA-8956739]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064591 |
protein Z-dependent protease inhibitor, signal peptide removed phosphorylated form (human)
|
hSERPINA10/SigPep-/PhosRes+
|
"A protein Z-dependent protease inhibitor (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:Q9UK55, 22-444, MOD:00696." [PRO:DNx, Reactome:R-HSA-8956990]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014680 |
serpin A11
|
SERPINA11
|
"A serpin that is a translation product of the human SERPINA11 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q7TPA5 |
serpin A11 (rat)
|
rSERPINA11
|
"A serpin A11 that is encoded in the genome of rat." [OMA:Q7TPA5, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q7TPA5-1 |
serpin A11 isoform 1 (rat)
|
rSERPINA11/iso:1
|
"A serpin A11 isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q7TPA5-2 |
serpin A11 isoform r2 (rat)
|
rSERPINA11/iso:r2
|
"A serpin A11 (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7TPA5-2." [PRO:DNx, UniProtKB:Q7TPA5]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q86U17 |
serpin A11 (human)
|
hSERPINA11
|
"A serpin A11 that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q86U17]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86U17-1 |
serpin A11 isoform 1 (human)
|
hSERPINA11/iso:1
|
"A serpin A11 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000080838 |
serpin A11 deaminated 1 (human)
|
hSERPINA11/Deam:1
|
"A serpin A11 (human) that has been deaminated on the residue at the position equivalent to Asn-350 of the amino acid sequence represented by UniProtKB:Q86U17. UniProtKB:Q86U17, Asn-350, MOD:00684." [IEDB_epitope:1367292, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q8CIE0 |
serpin A11 (mouse)
|
mSERPINA11
|
"A serpin A11 that is encoded in the genome of mouse." [OMA:Q8CIE0, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000041488 |
serpin A11 isoform 1
|
SERPINA11/iso:1
|
"A serpin A11 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86U17-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q7TPA5-1 |
serpin A11 isoform 1 (rat)
|
rSERPINA11/iso:1
|
"A serpin A11 isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86U17-1 |
serpin A11 isoform 1 (human)
|
hSERPINA11/iso:1
|
"A serpin A11 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014681 |
serpin A12
|
SERPINA12
|
"A serpin that is a translation product of the human SERPINA12 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q7TMF5 |
serpin A12 (mouse)
|
mSERPINA12
|
"A serpin A12 that is encoded in the genome of mouse." [OMA:Q7TMF5, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q8IW75 |
serpin A12 (human)
|
hSERPINA12
|
"A serpin A12 that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q8IW75]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q8R4Z1 |
serpin A12 (rat)
|
rSERPINA12
|
"A serpin A12 that is encoded in the genome of rat." [OMA:Q8R4Z1, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9VLU4 |
serine protease inhibitor 28Dc (fruit fly)
|
fly-SERPINA12
|
"A serpin A12 that is encoded in the genome of fruit fly." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021420 |
serpin A12, signal peptide removed form
|
SERPINA12/SigPep-
|
"A serpin A12 that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014682 |
putative serpin A13
|
SERPINA13P
|
"A serpin that is a translation product of the human SERPINA13P gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q6UXR4 |
putative serpin A13 (human)
|
hSERPINA13P
|
"A putative serpin A13 that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q6UXR4]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014683 |
alpha-1-antichymotrypsin
|
SERPINA3
|
"A serpin that is a translation product of the human SERPINA3 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P01011 |
alpha-1-antichymotrypsin (human)
|
hSERPINA3
|
"An alpha-1-antichymotrypsin that is encoded in the genome of human." [PRO:CNA, UniProtKB:P01011]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01011-1 |
alpha-1-antichymotrypsin isoform 1 (human)
|
hSERPINA3/iso:1
|
"An alpha-1-antichymotrypsin isoform 1 that is encoded in the genome of human." [PRO:CNx]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035630 |
alpha-1-antichymotrypsin isoform 1, signal peptide removed form (human)
|
hSERPINA3/iso:1/SigPep-
|
"An alpha-1-antichymotrypsin isoform 1, signal peptide removed form in human. UniProtKB:P01011-1, 24-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035632 |
alpha-1-antichymotrypsin isoform 1 His-Pro-less (human)
|
hSERPINA3/iso:1/SigPep-/(HisPro)-
|
"An alpha-1-antichymotrypsin isoform 1 His-Pro-less in human. UniProtKB:P01011-1, 26-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035634 |
alpha-1-antichymotrypsin isoform 1, initiator methionine removed acetylated 1 (human)
|
hSERPINA3/iso:1/InitMet-/Ac:1
|
"An alpha-1-antichymotrypsin isoform 1, initiator methionine removed acetylated 1 in human. UniProtKB:P01011-1, 2-423, Glu-2, MOD:00053." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01011-2 |
alpha-1-antichymotrypsin isoform h2 (human)
|
hSERPINA3/iso:h2
|
"An alpha-1-antichymotrypsin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01011-2." [PRO:DNx, UniProtKB:P01011]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01011-3 |
alpha-1-antichymotrypsin isoform h3 (human)
|
hSERPINA3/iso:h3
|
"An alpha-1-antichymotrypsin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01011-3." [PRO:DNx, UniProtKB:P01011]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051407 |
alpha-1-antichymotrypsin N-glycosylated 1 (human)
|
hSERPINA3/NGlyco:1
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-106 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01011-1, Asn-106, MOD:00160~GNO:G06247RL." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051408 |
alpha-1-antichymotrypsin N-glycosylated 2 (human)
|
hSERPINA3/NGlyco:2
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-106 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G11115RO. Example: UniProtKB:P01011-1, Asn-106, MOD:00160~GNO:G11115RO." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051409 |
alpha-1-antichymotrypsin N-glycosylated 3 (human)
|
hSERPINA3/NGlyco:3
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-106 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P01011-1, Asn-106, MOD:00160~GNO:G42358LZ." [GlyGen:P01011-1, PMID:24279413, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051410 |
alpha-1-antichymotrypsin N-glycosylated 4 (human)
|
hSERPINA3/NGlyco:4
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-106 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan structure is represented by GlyTouCan:G93860XO. Example: UniProtKB:P01011-1, Asn-106, MOD:00160~GNO:G93860XO." [GlyGen:P01011-1, PMID:24279413, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051411 |
alpha-1-antichymotrypsin N-glycosylated 5 (human)
|
hSERPINA3/NGlyco:5
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-106 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01011-1, Asn-106, MOD:00160~GNO:G94917XT." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051412 |
alpha-1-antichymotrypsin N-glycosylated 6 (human)
|
hSERPINA3/NGlyco:6
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-106 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G95678HJ. Example: UniProtKB:P01011-1, Asn-106, MOD:00160~GNO:G95678HJ." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051413 |
alpha-1-antichymotrypsin N-glycosylated 7 (human)
|
hSERPINA3/NGlyco:7
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-127 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01011-1, Asn-127, MOD:00160~GNO:G00912UN." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051414 |
alpha-1-antichymotrypsin N-glycosylated 8 (human)
|
hSERPINA3/NGlyco:8
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-127 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01011-1, Asn-127, MOD:00160~GNO:G06247RL." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051415 |
alpha-1-antichymotrypsin N-glycosylated 9 (human)
|
hSERPINA3/NGlyco:9
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-127 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01011-1, Asn-127, MOD:00160~GNO:G27947YN." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051416 |
alpha-1-antichymotrypsin N-glycosylated 10 (human)
|
hSERPINA3/NGlyco:10
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-127 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P01011-1, Asn-127, MOD:00160~GNO:G40926MX." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051417 |
alpha-1-antichymotrypsin N-glycosylated 11 (human)
|
hSERPINA3/NGlyco:11
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-127 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan structure is represented by GlyTouCan:G66282NU. Example: UniProtKB:P01011-1, Asn-127, MOD:00160~GNO:G66282NU." [GlyGen:P01011-1, PMID:2015821, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051418 |
alpha-1-antichymotrypsin N-glycosylated 12 (human)
|
hSERPINA3/NGlyco:12
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-127 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P01011-1, Asn-127, MOD:00160~GNO:G84467IZ." [GlyGen:P01011-1, PMID:2015821, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051419 |
alpha-1-antichymotrypsin N-glycosylated 13 (human)
|
hSERPINA3/NGlyco:13
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-127 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan structure is represented by GlyTouCan:G89877QI. Example: UniProtKB:P01011-1, Asn-127, MOD:00160~GNO:G89877QI." [GlyGen:P01011-1, PMID:2015821, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051420 |
alpha-1-antichymotrypsin N-glycosylated 14 (human)
|
hSERPINA3/NGlyco:14
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-127 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01011-1, Asn-127, MOD:00160~GNO:G94917XT." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051421 |
alpha-1-antichymotrypsin N-glycosylated 15 (human)
|
hSERPINA3/NGlyco:15
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G00912UN." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051422 |
alpha-1-antichymotrypsin N-glycosylated 16 (human)
|
hSERPINA3/NGlyco:16
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G06247RL." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051423 |
alpha-1-antichymotrypsin N-glycosylated 17 (human)
|
hSERPINA3/NGlyco:17
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G11115RO. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G11115RO." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051424 |
alpha-1-antichymotrypsin N-glycosylated 18 (human)
|
hSERPINA3/NGlyco:18
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G27947YN." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051425 |
alpha-1-antichymotrypsin N-glycosylated 19 (human)
|
hSERPINA3/NGlyco:19
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G40926MX." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051426 |
alpha-1-antichymotrypsin N-glycosylated 20 (human)
|
hSERPINA3/NGlyco:20
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G41044JW. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G41044JW." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051427 |
alpha-1-antichymotrypsin N-glycosylated 21 (human)
|
hSERPINA3/NGlyco:21
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G85144OK." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051428 |
alpha-1-antichymotrypsin N-glycosylated 22 (human)
|
hSERPINA3/NGlyco:22
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G94917XT." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051429 |
alpha-1-antichymotrypsin N-glycosylated 23 (human)
|
hSERPINA3/NGlyco:23
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G95678HJ. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G95678HJ." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051430 |
alpha-1-antichymotrypsin N-glycosylated 24 (human)
|
hSERPINA3/NGlyco:24
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-271 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G99679NM. Example: UniProtKB:P01011-1, Asn-271, MOD:00160~GNO:G99679NM." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051431 |
alpha-1-antichymotrypsin N-glycosylated 25 (human)
|
hSERPINA3/NGlyco:25
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-93 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01011-1, Asn-93, MOD:00160~GNO:G00912UN." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051432 |
alpha-1-antichymotrypsin N-glycosylated 26 (human)
|
hSERPINA3/NGlyco:26
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-93 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01011-1, Asn-93, MOD:00160~GNO:G06247RL." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051433 |
alpha-1-antichymotrypsin N-glycosylated 27 (human)
|
hSERPINA3/NGlyco:27
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-93 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01011-1, Asn-93, MOD:00160~GNO:G27947YN." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051434 |
alpha-1-antichymotrypsin N-glycosylated 28 (human)
|
hSERPINA3/NGlyco:28
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-93 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01011-1, Asn-93, MOD:00160~GNO:G59626AS." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051435 |
alpha-1-antichymotrypsin N-glycosylated 29 (human)
|
hSERPINA3/NGlyco:29
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-93 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan structure is represented by GlyTouCan:G66282NU. Example: UniProtKB:P01011-1, Asn-93, MOD:00160~GNO:G66282NU." [GlyGen:P01011-1, PMID:2015821, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051436 |
alpha-1-antichymotrypsin N-glycosylated 30 (human)
|
hSERPINA3/NGlyco:30
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-93 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan structure is represented by GlyTouCan:G84467IZ. Example: UniProtKB:P01011-1, Asn-93, MOD:00160~GNO:G84467IZ." [GlyGen:P01011-1, PMID:2015821, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051437 |
alpha-1-antichymotrypsin N-glycosylated 31 (human)
|
hSERPINA3/NGlyco:31
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-93 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan structure is represented by GlyTouCan:G89877QI. Example: UniProtKB:P01011-1, Asn-93, MOD:00160~GNO:G89877QI." [GlyGen:P01011-1, PMID:2015821, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051438 |
alpha-1-antichymotrypsin N-glycosylated 32 (human)
|
hSERPINA3/NGlyco:32
|
"An alpha-1-antichymotrypsin (human) that has been N-glycosylated at the residue equivalent to Asn-93 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01011-1, Asn-93, MOD:00160~GNO:G94917XT." [GlyGen:P01011-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051439 |
alpha-1-antichymotrypsin O-glycosylated 1 (human)
|
hSERPINA3/OGlyco:1
|
"An alpha-1-antichymotrypsin (human) that has been O-glycosylated at the residue equivalent to Ser-373 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01011-1, Ser-373, MOD:00002~GNO:G29068FM." [GlyGen:P01011-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051440 |
alpha-1-antichymotrypsin O-glycosylated 2 (human)
|
hSERPINA3/OGlyco:2
|
"An alpha-1-antichymotrypsin (human) that has been O-glycosylated at the residue equivalent to Ser-373 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01011-1, Ser-373, MOD:00002~GNO:G43417UB." [GlyGen:P01011-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000051441 |
alpha-1-antichymotrypsin O-glycosylated 3 (human)
|
hSERPINA3/OGlyco:3
|
"An alpha-1-antichymotrypsin (human) that has been O-glycosylated at the residue equivalent to Thr-381 of the amino acid sequence represented by UniProtKB:P01011-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01011-1, Thr-381, MOD:00005~GNO:G43417UB." [GlyGen:P01011-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000084644 |
alpha-1-antichymotrypsin methylated 1 (human)
|
hSERPINA3/Me:1
|
"An alpha-1-antichymotrypsin (human) that has been methylated on the residue at the position equivalent to Cys-18 of the amino acid sequence represented by UniProtKB:P01011-1. Example: UniProtKB:P01011-1, Cys-18, MOD:00660." [IEDB_epitope:1029738, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000085093 |
alpha-1-antichymotrypsin cysteinylated 1 (human)
|
hSERPINA3/Cyst:1
|
"An alpha-1-antichymotrypsin (human) that has been cysteinylated on the residue at the position equivalent to Cys-18 of the amino acid sequence represented by UniProtKB:P01011-1. Example: UniProtKB:P01011-1, Cys-18, MOD:00765." [IEDB_epitope:775150, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000085826 |
alpha-1-antichymotrypsin, signal peptide removed form (human)
|
hSERPINA3/SigPep-
|
"An alpha-1-antichymotrypsin (human) that has had the signal peptide removed. Example: UniProtKB:P01011-1, 24-423." [PRO:DNx, Reactome:R-HSA-6798754, Reactome:R-HSA-6801018, Reactome:R-HSA-6806173, Reactome:R-HSA-8848913]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035630 |
alpha-1-antichymotrypsin isoform 1, signal peptide removed form (human)
|
hSERPINA3/iso:1/SigPep-
|
"An alpha-1-antichymotrypsin isoform 1, signal peptide removed form in human. UniProtKB:P01011-1, 24-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000035627 |
alpha-1-antichymotrypsin isoform 1
|
SERPINA3/iso:1
|
"An alpha-1-antichymotrypsin that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01011-1 or a 1:1 ortholog thereof." [PRO:CNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01011-1 |
alpha-1-antichymotrypsin isoform 1 (human)
|
hSERPINA3/iso:1
|
"An alpha-1-antichymotrypsin isoform 1 that is encoded in the genome of human." [PRO:CNx]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035630 |
alpha-1-antichymotrypsin isoform 1, signal peptide removed form (human)
|
hSERPINA3/iso:1/SigPep-
|
"An alpha-1-antichymotrypsin isoform 1, signal peptide removed form in human. UniProtKB:P01011-1, 24-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035632 |
alpha-1-antichymotrypsin isoform 1 His-Pro-less (human)
|
hSERPINA3/iso:1/SigPep-/(HisPro)-
|
"An alpha-1-antichymotrypsin isoform 1 His-Pro-less in human. UniProtKB:P01011-1, 26-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035634 |
alpha-1-antichymotrypsin isoform 1, initiator methionine removed acetylated 1 (human)
|
hSERPINA3/iso:1/InitMet-/Ac:1
|
"An alpha-1-antichymotrypsin isoform 1, initiator methionine removed acetylated 1 in human. UniProtKB:P01011-1, 2-423, Glu-2, MOD:00053." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000035629 |
alpha-1-antichymotrypsin isoform 1, signal peptide removed form
|
SERPINA3/iso:1/SigPep-
|
"An alpha-1-antichymotrypsin isoform 1 that has had the signal peptide removed to yield a mature protein. Example: UniProtKB:P01011-1, 24-423." [PRO:CNx]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035630 |
alpha-1-antichymotrypsin isoform 1, signal peptide removed form (human)
|
hSERPINA3/iso:1/SigPep-
|
"An alpha-1-antichymotrypsin isoform 1, signal peptide removed form in human. UniProtKB:P01011-1, 24-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000035631 |
alpha-1-antichymotrypsin isoform 1 His-Pro-less
|
SERPINA3/iso:1/SigPep-/(HisPro)-
|
"An alpha-1-antichymotrypsin isoform 1 that has had the signal peptide removed and further processed to remove the two most N-terminal residues. Example: UniProtKB:P01011-1, 26-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035632 |
alpha-1-antichymotrypsin isoform 1 His-Pro-less (human)
|
hSERPINA3/iso:1/SigPep-/(HisPro)-
|
"An alpha-1-antichymotrypsin isoform 1 His-Pro-less in human. UniProtKB:P01011-1, 26-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000035633 |
alpha-1-antichymotrypsin isoform 1, initiator methionine removed acetylated 1
|
SERPINA3/iso:1/InitMet-/Ac:1
|
"An alpha-1-antichymotrypsin isoform 1 that has had the initiator methionine removed and has been post-translationally modified to include an acetylated residue at the N terminus. Example: UniProtKB:P01011-1, 2-423, Glu-2, MOD:00053." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035634 |
alpha-1-antichymotrypsin isoform 1, initiator methionine removed acetylated 1 (human)
|
hSERPINA3/iso:1/InitMet-/Ac:1
|
"An alpha-1-antichymotrypsin isoform 1, initiator methionine removed acetylated 1 in human. UniProtKB:P01011-1, 2-423, Glu-2, MOD:00053." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021422 |
alpha-1-antichymotrypsin, signal peptide removed form
|
SERPINA3/SigPep-
|
"An alpha-1-antichymotrypsin that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000035629 |
alpha-1-antichymotrypsin isoform 1, signal peptide removed form
|
SERPINA3/iso:1/SigPep-
|
"An alpha-1-antichymotrypsin isoform 1 that has had the signal peptide removed to yield a mature protein. Example: UniProtKB:P01011-1, 24-423." [PRO:CNx]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035630 |
alpha-1-antichymotrypsin isoform 1, signal peptide removed form (human)
|
hSERPINA3/iso:1/SigPep-
|
"An alpha-1-antichymotrypsin isoform 1, signal peptide removed form in human. UniProtKB:P01011-1, 24-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000085826 |
alpha-1-antichymotrypsin, signal peptide removed form (human)
|
hSERPINA3/SigPep-
|
"An alpha-1-antichymotrypsin (human) that has had the signal peptide removed. Example: UniProtKB:P01011-1, 24-423." [PRO:DNx, Reactome:R-HSA-6798754, Reactome:R-HSA-6801018, Reactome:R-HSA-6806173, Reactome:R-HSA-8848913]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000035630 |
alpha-1-antichymotrypsin isoform 1, signal peptide removed form (human)
|
hSERPINA3/iso:1/SigPep-
|
"An alpha-1-antichymotrypsin isoform 1, signal peptide removed form in human. UniProtKB:P01011-1, 24-423." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021423 |
alpha-1-antichymotrypsin proteolytic cleavage product
|
SERPINA3/ClvPrd
|
"An alpha-1-antichymotrypsin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014684 |
kallistatin
|
SERPINA4
|
"A serpin that is a translation product of the human SERPINA4 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P29622 |
kallistatin (human)
|
hSERPINA4
|
"A kallistatin that is encoded in the genome of human." [PRO:CNA, UniProtKB:P29622]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049205 |
kallistatin, signal peptide removed form (human)
|
hSERPINA4/SigPep-
|
"A kallistatin (human) that has had the signal peptide removed. UniProtKB:P29622, 21-427." [PRO:DNx, Reactome:R-HSA-8848886, Reactome:R-HSA-8848911]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056331 |
kallistatin N-glycosylated 1 (human)
|
hSERPINA4/NGlyco:1
|
"A kallistatin (human) that has been N-glycosylated at the residue equivalent to Asn-108 of the amino acid sequence represented by UniProtKB:P29622-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P29622-1, Asn-108, MOD:00160~GNO:G06247RL." [GlyGen:P29622-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056332 |
kallistatin N-glycosylated 2 (human)
|
hSERPINA4/NGlyco:2
|
"A kallistatin (human) that has been N-glycosylated at the residue equivalent to Asn-108 of the amino acid sequence represented by UniProtKB:P29622-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P29622-1, Asn-108, MOD:00160~GNO:G94917XT." [GlyGen:P29622-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056333 |
kallistatin N-glycosylated 3 (human)
|
hSERPINA4/NGlyco:3
|
"A kallistatin (human) that has been N-glycosylated at the residue equivalent to Asn-157 of the amino acid sequence represented by UniProtKB:P29622-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P29622-1, Asn-157, MOD:00160~GNO:G00912UN." [GlyGen:P29622-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056334 |
kallistatin N-glycosylated 4 (human)
|
hSERPINA4/NGlyco:4
|
"A kallistatin (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P29622-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P29622-1, Asn-238, MOD:00160~GNO:G00912UN." [GlyGen:P29622-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056335 |
kallistatin N-glycosylated 5 (human)
|
hSERPINA4/NGlyco:5
|
"A kallistatin (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P29622-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P29622-1, Asn-238, MOD:00160~GNO:G06247RL." [GlyGen:P29622-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056336 |
kallistatin N-glycosylated 6 (human)
|
hSERPINA4/NGlyco:6
|
"A kallistatin (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P29622-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P29622-1, Asn-238, MOD:00160~GNO:G27947YN." [GlyGen:P29622-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056337 |
kallistatin N-glycosylated 7 (human)
|
hSERPINA4/NGlyco:7
|
"A kallistatin (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P29622-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P29622-1, Asn-238, MOD:00160~GNO:G94917XT." [GlyGen:P29622-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000069868 |
kallistatin phosphorylated 1 (human)
|
hSERPINA4/Phos:1
|
"A kallistatin (human) that has been phosphorylated on the residue at the position equivalent to Ser-83 of the amino acid sequence represented by UniProtKB:P29622. UniProtKB:P29622, Ser-83, MOD:00046." [IEDB_epitope:1353787, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014685 |
plasma serine protease inhibitor
|
SERPINA5
|
"A serpin that is a translation product of the human SERPINA5 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P05154 |
plasma serine protease inhibitor (human)
|
hSERPINA5
|
"A plasma serine protease inhibitor that is encoded in the genome of human." [PRO:CNA, UniProtKB:P05154]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053460 |
plasma serine protease inhibitor N-glycosylated 1 (human)
|
hSERPINA5/NGlyco:1
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G26271XI. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G26271XI." [GlyGen:P05154-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053461 |
plasma serine protease inhibitor N-glycosylated 2 (human)
|
hSERPINA5/NGlyco:2
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G37399XV. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G37399XV." [GlyGen:P05154-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053462 |
plasma serine protease inhibitor N-glycosylated 3 (human)
|
hSERPINA5/NGlyco:3
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G41126SR. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G41126SR." [GlyGen:P05154-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053463 |
plasma serine protease inhibitor N-glycosylated 4 (human)
|
hSERPINA5/NGlyco:4
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G60923RB. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G60923RB." [GlyGen:P05154-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053464 |
plasma serine protease inhibitor N-glycosylated 5 (human)
|
hSERPINA5/NGlyco:5
|
"A plasma serine protease inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-262 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G87051GH. Example: UniProtKB:P05154-1, Asn-262, MOD:00160~GNO:G87051GH." [GlyGen:P05154-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053465 |
plasma serine protease inhibitor O-glycosylated 1 (human)
|
hSERPINA5/OGlyco:1
|
"A plasma serine protease inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-39 of the amino acid sequence represented by UniProtKB:P05154-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05154-1, Thr-39, MOD:00005~GNO:G43417UB." [GlyGen:P05154-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000070093 |
plasma serine protease inhibitor, mature form (human)
|
hSERPINA5/mature
|
"A plasma serine protease inhibitor (human) that has had the signal peptide and propeptide removed. UniProtKB:P05154, 26-406." [PRO:DNx, Reactome:R-HSA-5591085]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P70458 |
plasma serine protease inhibitor (mouse)
|
mSERPINA5
|
"A plasma serine protease inhibitor that is encoded in the genome of mouse." [OMA:P70458, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021425 |
plasma serine protease inhibitor, signal peptide removed form
|
SERPINA5/SigPep-
|
"A plasma serine protease inhibitor that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000070093 |
plasma serine protease inhibitor, mature form (human)
|
hSERPINA5/mature
|
"A plasma serine protease inhibitor (human) that has had the signal peptide and propeptide removed. UniProtKB:P05154, 26-406." [PRO:DNx, Reactome:R-HSA-5591085]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014686 |
corticosteroid-binding globulin
|
SERPINA6
|
"A serpin that is a translation product of the human SERPINA6 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P08185 |
corticosteroid-binding globulin (human)
|
hSERPINA6
|
"A corticosteroid-binding globulin that is encoded in the genome of human." [PRO:CNA, UniProtKB:P08185]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054423 |
corticosteroid-binding globulin N-glycosylated 1 (human)
|
hSERPINA6/NGlyco:1
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G00912UN." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054424 |
corticosteroid-binding globulin N-glycosylated 2 (human)
|
hSERPINA6/NGlyco:2
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G06247RL." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054425 |
corticosteroid-binding globulin N-glycosylated 3 (human)
|
hSERPINA6/NGlyco:3
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G08293MJ." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054426 |
corticosteroid-binding globulin N-glycosylated 4 (human)
|
hSERPINA6/NGlyco:4
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G12580WI." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054427 |
corticosteroid-binding globulin N-glycosylated 5 (human)
|
hSERPINA6/NGlyco:5
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G45504EY. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G45504EY." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054428 |
corticosteroid-binding globulin N-glycosylated 6 (human)
|
hSERPINA6/NGlyco:6
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G54600FO. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G54600FO." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054429 |
corticosteroid-binding globulin N-glycosylated 7 (human)
|
hSERPINA6/NGlyco:7
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G59937CP. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G59937CP." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054430 |
corticosteroid-binding globulin N-glycosylated 8 (human)
|
hSERPINA6/NGlyco:8
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G83555HU. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G83555HU." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054431 |
corticosteroid-binding globulin N-glycosylated 9 (human)
|
hSERPINA6/NGlyco:9
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G88725PI. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G88725PI." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054432 |
corticosteroid-binding globulin N-glycosylated 10 (human)
|
hSERPINA6/NGlyco:10
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-31 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P08185-1, Asn-31, MOD:00160~GNO:G94917XT." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054433 |
corticosteroid-binding globulin N-glycosylated 11 (human)
|
hSERPINA6/NGlyco:11
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-96 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P08185-1, Asn-96, MOD:00160~GNO:G00912UN." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054434 |
corticosteroid-binding globulin N-glycosylated 12 (human)
|
hSERPINA6/NGlyco:12
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-96 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P08185-1, Asn-96, MOD:00160~GNO:G06247RL." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054435 |
corticosteroid-binding globulin N-glycosylated 13 (human)
|
hSERPINA6/NGlyco:13
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-96 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P08185-1, Asn-96, MOD:00160~GNO:G40926MX." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054436 |
corticosteroid-binding globulin N-glycosylated 14 (human)
|
hSERPINA6/NGlyco:14
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-96 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P08185-1, Asn-96, MOD:00160~GNO:G42358LZ." [GlyGen:P08185-1, PMID:24279413, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054437 |
corticosteroid-binding globulin N-glycosylated 15 (human)
|
hSERPINA6/NGlyco:15
|
"A corticosteroid-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-96 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P08185-1, Asn-96, MOD:00160~GNO:G59626AS." [GlyGen:P08185-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054438 |
corticosteroid-binding globulin O-glycosylated 1 (human)
|
hSERPINA6/OGlyco:1
|
"A corticosteroid-binding globulin (human) that has been O-glycosylated at the residue equivalent to Thr-364 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P08185-1, Thr-364, MOD:00005~GNO:G29068FM." [GlyGen:P08185-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054439 |
corticosteroid-binding globulin O-glycosylated 2 (human)
|
hSERPINA6/OGlyco:2
|
"A corticosteroid-binding globulin (human) that has been O-glycosylated at the residue equivalent to Thr-364 of the amino acid sequence represented by UniProtKB:P08185-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P08185-1, Thr-364, MOD:00005~GNO:G43417UB." [GlyGen:P08185-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000064367 |
corticosteroid-binding globulin, signal peptide removed form (human)
|
hSERPINA6/SigPep-
|
"A corticosteroid-binding globulin (human) that has had the signal peptide removed. UniProtKB:P08185, 23-405." [PRO:DNx, Reactome:R-HSA-1449658]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P31211 |
corticosteroid-binding globulin (rat)
|
rSERPINA6
|
"A corticosteroid-binding globulin that is encoded in the genome of rat." [OMA:P31211, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q06770 |
corticosteroid-binding globulin (mouse)
|
mSERPINA6
|
"A corticosteroid-binding globulin that is encoded in the genome of mouse." [OMA:Q06770, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021427 |
corticosteroid-binding globulin, signal peptide removed form
|
SERPINA6/SigPep-
|
"A corticosteroid-binding globulin that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000064367 |
corticosteroid-binding globulin, signal peptide removed form (human)
|
hSERPINA6/SigPep-
|
"A corticosteroid-binding globulin (human) that has had the signal peptide removed. UniProtKB:P08185, 23-405." [PRO:DNx, Reactome:R-HSA-1449658]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014687 |
thyroxine-binding globulin
|
SERPINA7
|
"A serpin that is a translation product of the human SERPINA7 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P05543 |
thyroxine-binding globulin (human)
|
hSERPINA7
|
"A thyroxine-binding globulin that is encoded in the genome of human." [PRO:CNA, UniProtKB:P05543]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053538 |
thyroxine-binding globulin N-glycosylated 1 (human)
|
hSERPINA7/NGlyco:1
|
"A thyroxine-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-36 of the amino acid sequence represented by UniProtKB:P05543-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P05543-1, Asn-36, MOD:00160~GNO:G00912UN." [GlyGen:P05543-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053539 |
thyroxine-binding globulin N-glycosylated 2 (human)
|
hSERPINA7/NGlyco:2
|
"A thyroxine-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-36 of the amino acid sequence represented by UniProtKB:P05543-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P05543-1, Asn-36, MOD:00160~GNO:G10486CT." [GlyGen:P05543-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053540 |
thyroxine-binding globulin N-glycosylated 3 (human)
|
hSERPINA7/NGlyco:3
|
"A thyroxine-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-36 of the amino acid sequence represented by UniProtKB:P05543-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P05543-1, Asn-36, MOD:00160~GNO:G22140GZ." [GlyGen:P05543-1, PMID:19838169, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053541 |
thyroxine-binding globulin N-glycosylated 4 (human)
|
hSERPINA7/NGlyco:4
|
"A thyroxine-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-36 of the amino acid sequence represented by UniProtKB:P05543-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P05543-1, Asn-36, MOD:00160~GNO:G27947YN." [GlyGen:P05543-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053542 |
thyroxine-binding globulin N-glycosylated 5 (human)
|
hSERPINA7/NGlyco:5
|
"A thyroxine-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-36 of the amino acid sequence represented by UniProtKB:P05543-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P05543-1, Asn-36, MOD:00160~GNO:G59626AS." [GlyGen:P05543-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053543 |
thyroxine-binding globulin N-glycosylated 6 (human)
|
hSERPINA7/NGlyco:6
|
"A thyroxine-binding globulin (human) that has been N-glycosylated at the residue equivalent to Asn-36 of the amino acid sequence represented by UniProtKB:P05543-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P05543-1, Asn-36, MOD:00160~GNO:G88374WZ." [GlyGen:P05543-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053544 |
thyroxine-binding globulin O-glycosylated 1 (human)
|
hSERPINA7/OGlyco:1
|
"A thyroxine-binding globulin (human) that has been O-glycosylated at the residue equivalent to Ser-373 of the amino acid sequence represented by UniProtKB:P05543-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05543-1, Ser-373, MOD:00002~GNO:G43417UB." [GlyGen:P05543-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P35577 |
thyroxine-binding globulin (rat)
|
rSERPINA7
|
"A thyroxine-binding globulin that is encoded in the genome of rat." [OMA:P35577, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P35577-1 |
thyroxine-binding globulin isoform 1 (rat)
|
rSERPINA7/iso:1
|
"A thyroxine-binding globulin isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P61939 |
thyroxine-binding globulin (mouse)
|
mSERPINA7
|
"A thyroxine-binding globulin that is encoded in the genome of mouse." [OMA:P61939, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P61939-1 |
thyroxine-binding globulin isoform 1 (mouse)
|
mSERPINA7/iso:1
|
"A thyroxine-binding globulin isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000039958 |
thyroxine-binding globulin isoform 1
|
SERPINA7/iso:1
|
"A thyroxine-binding globulin that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P61939-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P35577-1 |
thyroxine-binding globulin isoform 1 (rat)
|
rSERPINA7/iso:1
|
"A thyroxine-binding globulin isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P61939-1 |
thyroxine-binding globulin isoform 1 (mouse)
|
mSERPINA7/iso:1
|
"A thyroxine-binding globulin isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021429 |
thyroxine-binding globulin, signal peptide removed form
|
SERPINA7/SigPep-
|
"A thyroxine-binding globulin that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014688 |
serpin A9
|
SERPINA9
|
"A serpin that is a translation product of the human SERPINA9 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:D3ZAT4 |
protein Serpina9 (rat)
|
rSERPINA9
|
"A serpin A9 that is encoded in the genome of rat." [OMA:D3ZAT4, PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:E1C206 |
uncharacterized protein, SERPINA5 translation product (chicken)
|
chick-SERPINA9
|
"A serpin A9 that is encoded in the genome of chicken." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q86WD7 |
serpin A9 (human)
|
hSERPINA9
|
"A serpin A9 that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q86WD7]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86WD7-1 |
serpin A9 isoform h1 (human)
|
hSERPINA9/iso:h1
|
"A serpin A9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86WD7-1." [PRO:DNx, UniProtKB:Q86WD7]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86WD7-2 |
serpin A9 isoform h2 (human)
|
hSERPINA9/iso:h2
|
"A serpin A9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86WD7-2." [PRO:DNx, UniProtKB:Q86WD7]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86WD7-3 |
serpin A9 isoform h3 (human)
|
hSERPINA9/iso:h3
|
"A serpin A9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86WD7-3." [PRO:DNx, UniProtKB:Q86WD7]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86WD7-4 |
serpin A9 isoform h4 (human)
|
hSERPINA9/iso:h4
|
"A serpin A9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86WD7-4." [PRO:DNx, UniProtKB:Q86WD7]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86WD7-5 |
serpin A9 isoform h5 (human)
|
hSERPINA9/iso:h5
|
"A serpin A9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86WD7-5." [PRO:DNx, UniProtKB:Q86WD7]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86WD7-6 |
serpin A9 isoform h6 (human)
|
hSERPINA9/iso:h6
|
"A serpin A9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86WD7-6." [PRO:DNx, UniProtKB:Q86WD7]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q86WD7-7 |
serpin A9 isoform h7 (human)
|
hSERPINA9/iso:h7
|
"A serpin A9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86WD7-7." [PRO:DNx, UniProtKB:Q86WD7]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9D7D2 |
serpin A9 (mouse)
|
mSERPINA9
|
"A serpin A9 that is encoded in the genome of mouse." [OMA:Q9D7D2, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014689 |
leukocyte elastase inhibitor
|
SERPINB1
|
"A serpin that is a translation product of the human SERPINB1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P30740 |
leukocyte elastase inhibitor (human)
|
hSERPINB1
|
"A leukocyte elastase inhibitor that is encoded in the genome of human." [PRO:CNA, UniProtKB:P30740]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P30740-1 |
leukocyte elastase inhibitor isoform h1 (human)
|
hSERPINB1/iso:h1
|
"A leukocyte elastase inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P30740-1." [PRO:DNx, UniProtKB:P30740]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P30740-2 |
leukocyte elastase inhibitor isoform h2 (human)
|
hSERPINB1/iso:h2
|
"A leukocyte elastase inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P30740-2." [PRO:DNx, UniProtKB:P30740]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q6DG30 |
serpin peptidase inhibitor, clade B (Ovalbumin), member 1 (zebrafish)
|
z-SERPINB1
|
"A leukocyte elastase inhibitor that is encoded in the genome of zebrafish." [OMA:Q6DG30, PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014690 |
serpin B10
|
SERPINB10
|
"A serpin that is a translation product of the human SERPINB10 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:O73790 |
heterochromatin-associated protein MENT (chicken)
|
chick-SERPINB10
|
"A serpin B10 that is encoded in the genome of chicken." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P48595 |
serpin B10 (human)
|
hSERPINB10
|
"A serpin B10 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P48595]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P48595-1 |
serpin B10 isoform 1 (human)
|
hSERPINB10/iso:1
|
"A serpin B10 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q8K1K6 |
serpin B10 (mouse)
|
mSERPINB10
|
"A serpin B10 that is encoded in the genome of mouse." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q8K1K6-1 |
serpin B10 isoform 1 (mouse)
|
mSERPINB10/iso:1
|
"A serpin B10 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q8K3K4 |
serpin B10 (rat)
|
rSERPINB10
|
"A serpin B10 that is encoded in the genome of rat." [OMA:Q8K3K4, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000039551 |
serpin B10 isoform 1
|
SERPINB10/iso:1
|
"A serpin B10 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P48595-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P48595-1 |
serpin B10 isoform 1 (human)
|
hSERPINB10/iso:1
|
"A serpin B10 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q8K1K6-1 |
serpin B10 isoform 1 (mouse)
|
mSERPINB10/iso:1
|
"A serpin B10 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014691 |
serpin B11
|
SERPINB11
|
"A serpin that is a translation product of the human SERPINB11 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q96P15 |
serpin B11 (human)
|
hSERPINB11
|
"A serpin B11 that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q96P15]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q96P15-1 |
serpin B11 isoform h1 (human)
|
hSERPINB11/iso:h1
|
"A serpin B11 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96P15-1." [PRO:DNx, UniProtKB:Q96P15]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q96P15-2 |
serpin B11 isoform h2 (human)
|
hSERPINB11/iso:h2
|
"A serpin B11 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96P15-2." [PRO:DNx, UniProtKB:Q96P15]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q96P15-3 |
serpin B11 isoform h3 (human)
|
hSERPINB11/iso:h3
|
"A serpin B11 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96P15-3." [PRO:DNx, UniProtKB:Q96P15]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9CQV3 |
serpin B11 (mouse)
|
mSERPINB11
|
"A serpin B11 that is encoded in the genome of mouse." [OMA:Q9CQV3, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014692 |
serpin B12
|
SERPINB12
|
"A serpin that is a translation product of the human SERPINB12 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q96P63 |
serpin B12 (human)
|
hSERPINB12
|
"A serpin B12 that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q96P63]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q96P63-1 |
serpin B12 isoform h1 (human)
|
hSERPINB12/iso:h1
|
"A serpin B12 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96P63-1." [PRO:DNx, UniProtKB:Q96P63]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q96P63-2 |
serpin B12 isoform h2 (human)
|
hSERPINB12/iso:h2
|
"A serpin B12 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96P63-2." [PRO:DNx, UniProtKB:Q96P63]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9D7P9 |
serpin B12 (mouse)
|
mSERPINB12
|
"A serpin B12 that is encoded in the genome of mouse." [OMA:Q9D7P9, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014693 |
serpin B13
|
SERPINB13
|
"A serpin that is a translation product of the human SERPINB13 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q8CDC0 |
serpin B13 (mouse)
|
mSERPINB13
|
"A serpin B13 that is encoded in the genome of mouse." [OMA:Q8CDC0, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q8CDC0-1 |
serpin B13 isoform m1 (mouse)
|
mSERPINB13/iso:m1
|
"A serpin B13 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8CDC0-1." [PRO:DNx, UniProtKB:Q8CDC0]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q8CDC0-2 |
serpin B13 isoform m2 (mouse)
|
mSERPINB13/iso:m2
|
"A serpin B13 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8CDC0-2." [PRO:DNx, UniProtKB:Q8CDC0]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9UIV8 |
serpin B13 (human)
|
hSERPINB13
|
"A serpin B13 that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q9UIV8]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q9UIV8-1 |
serpin B13 isoform h1 (human)
|
hSERPINB13/iso:h1
|
"A serpin B13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UIV8-1." [PRO:DNx, UniProtKB:Q9UIV8]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q9UIV8-2 |
serpin B13 isoform h2 (human)
|
hSERPINB13/iso:h2
|
"A serpin B13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UIV8-2." [PRO:DNx, UniProtKB:Q9UIV8]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014694 |
serpin B3
|
SERPINB3
|
"A serpin that is a translation product of the human SERPINB3 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P29508 |
serpin B3 (human)
|
hSERPINB3
|
"A serpin B3 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P29508]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P29508-1 |
serpin B3 isoform h1 (human)
|
hSERPINB3/iso:h1
|
"A serpin B3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P29508-1." [PRO:DNx, UniProtKB:P29508]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P29508-2 |
serpin B3 isoform h2 (human)
|
hSERPINB3/iso:h2
|
"A serpin B3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P29508-2." [PRO:DNx, UniProtKB:P29508]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014695 |
serpin B4
|
SERPINB4
|
"A serpin that is a translation product of the human SERPINB4 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P48594 |
serpin B4 (human)
|
hSERPINB4
|
"A serpin B4 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P48594]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000065445 |
serpin B4 phosphorylated 1 (human)
|
hSERPINB4/Phos:1
|
"A serpin B4 (human) that has been phosphorylated on the residue at the position equivalent to Ser-242 of the amino acid sequence represented by UniProtKB:P48594. UniProtKB:P48594, Ser-242, MOD:00046." [IEDB_epitope:2146251, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000066089 |
serpin B4 citrullinated 1 (human)
|
hSERPINB4/Cit:1
|
"A serpin B4 (human) that has been citrullinated on the residue at the position equivalent to Arg-144 of the amino acid sequence represented by UniProtKB:P48594. UniProtKB:P48594, Arg-144, MOD:00219." [IEDB_epitope:911959, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014696 |
serpin B5
|
SERPINB5
|
"A serpin that is a translation product of the human SERPINB5 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P36952 |
serpin B5 (human)
|
hSERPINB5
|
"A serpin B5 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P36952]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P36952-1 |
serpin B5 isoform 1 (human)
|
hSERPINB5/iso:1
|
"A serpin B5 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P36952-2 |
serpin B5 isoform h2 (human)
|
hSERPINB5/iso:h2
|
"A serpin B5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P36952-2." [PRO:DNx, UniProtKB:P36952]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P70124 |
serpin B5 (mouse)
|
mSERPINB5
|
"A serpin B5 that is encoded in the genome of mouse." [OMA:P70124, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P70124-1 |
serpin B5 isoform 1 (mouse)
|
mSERPINB5/iso:1
|
"A serpin B5 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P70564 |
serpin B5 (rat)
|
rSERPINB5
|
"A serpin B5 that is encoded in the genome of rat." [OMA:P70564, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P70564-1 |
serpin B5 isoform 1 (rat)
|
rSERPINB5/iso:1
|
"A serpin B5 isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000039372 |
serpin B5 isoform 1
|
SERPINB5/iso:1
|
"A serpin B5 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P36952-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P36952-1 |
serpin B5 isoform 1 (human)
|
hSERPINB5/iso:1
|
"A serpin B5 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P70124-1 |
serpin B5 isoform 1 (mouse)
|
mSERPINB5/iso:1
|
"A serpin B5 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P70564-1 |
serpin B5 isoform 1 (rat)
|
rSERPINB5/iso:1
|
"A serpin B5 isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014697 |
serpin B6
|
SERPINB6
|
"A serpin that is a translation product of the human SERPINB6 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P35237 |
serpin B6 (human)
|
hSERPINB6
|
"A serpin B6 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P35237]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q60854 |
serpin B6 (mouse)
|
mSERPINB6
|
"A serpin B6 that is encoded in the genome of mouse." [OMA:Q60854, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014698 |
serpin B7
|
SERPINB7
|
"A serpin that is a translation product of the human SERPINB7 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:O75635 |
serpin B7 (human)
|
hSERPINB7
|
"A serpin B7 that is encoded in the genome of human." [PRO:CNA, UniProtKB:O75635]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O75635-1 |
serpin B7 isoform 1 (human)
|
hSERPINB7/iso:1
|
"A serpin B7 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O75635-2 |
serpin B7 isoform h2 (human)
|
hSERPINB7/iso:h2
|
"A serpin B7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75635-2." [PRO:DNx, UniProtKB:O75635]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000074379 |
serpin B7 deaminated 1 (human)
|
hSERPINB7/Deam:1
|
"A serpin B7 (human) that has been deaminated on the residue at the position equivalent to Asn-141 of the amino acid sequence represented by UniProtKB:O75635-1. Example: UniProtKB:O75635-1, Asn-141, MOD:00684." [IEDB_epitope:1331383, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000079804 |
serpin B7 deaminated 2 (human)
|
hSERPINB7/Deam:2
|
"A serpin B7 (human) that has been deaminated on the residue at the position equivalent to Gln-348 of the amino acid sequence represented by UniProtKB:O75635-1. Example: UniProtKB:O75635-1, Gln-348, MOD:00685." [IEDB_epitope:1977339, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9D695 |
serpin B7 (mouse)
|
mSERPINB7
|
"A serpin B7 that is encoded in the genome of mouse." [OMA:Q9D695, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q9D695-1 |
serpin B7 isoform 1 (mouse)
|
mSERPINB7/iso:1
|
"A serpin B7 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000038380 |
serpin B7 isoform 1
|
SERPINB7/iso:1
|
"A serpin B7 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75635-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O75635-1 |
serpin B7 isoform 1 (human)
|
hSERPINB7/iso:1
|
"A serpin B7 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q9D695-1 |
serpin B7 isoform 1 (mouse)
|
mSERPINB7/iso:1
|
"A serpin B7 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014699 |
serpin B8
|
SERPINB8
|
"A serpin that is a translation product of the human SERPINB8 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:O08800 |
serpin B8 (mouse)
|
mSERPINB8
|
"A serpin B8 that is encoded in the genome of mouse." [OMA:O08800, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O08800-1 |
serpin B8 isoform 1 (mouse)
|
mSERPINB8/iso:1
|
"A serpin B8 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P50452 |
serpin B8 (human)
|
hSERPINB8
|
"A serpin B8 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P50452]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P50452-1 |
serpin B8 isoform 1 (human)
|
hSERPINB8/iso:1
|
"A serpin B8 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P50452-2 |
serpin B8 isoform h2 (human)
|
hSERPINB8/iso:h2
|
"A serpin B8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P50452-2." [PRO:DNx, UniProtKB:P50452]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P50452-3 |
serpin B8 isoform h3 (human)
|
hSERPINB8/iso:h3
|
"A serpin B8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P50452-3." [PRO:DNx, UniProtKB:P50452]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000065688 |
serpin B8 deaminated 1 (human)
|
hSERPINB8/Deam:1
|
"A serpin B8 (human) that has been deaminated on the residue at the position equivalent to Asn-78 of the amino acid sequence represented by UniProtKB:P50452-1. Example: UniProtKB:P50452-1, Asn-78, MOD:00684." [IEDB_epitope:431111, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000080796 |
serpin B8 phosphorylated 1 (human)
|
hSERPINB8/Phos:1
|
"A serpin B8 (human) that has been phosphorylated on the residue at the position equivalent to Ser-49 of the amino acid sequence represented by UniProtKB:P50452-1. Example: UniProtKB:P50452-1, Ser-49, MOD:00046." [IEDB_epitope:2147496, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000039633 |
serpin B8 isoform 1
|
SERPINB8/iso:1
|
"A serpin B8 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P50452-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O08800-1 |
serpin B8 isoform 1 (mouse)
|
mSERPINB8/iso:1
|
"A serpin B8 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P50452-1 |
serpin B8 isoform 1 (human)
|
hSERPINB8/iso:1
|
"A serpin B8 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014700 |
serpin B9
|
SERPINB9
|
"A serpin that is a translation product of the human SERPINB9 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P50453 |
serpin B9 (human)
|
hSERPINB9
|
"A serpin B9 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P50453]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014701 |
heparin cofactor 2
|
SERPIND1
|
"A serpin that is a translation product of the human SERPIND1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:O04582 |
probable non-inhibitory serpin-Z5 (Arabidopsis thaliana)
|
At-SERPIND1
|
"A heparin cofactor 2 that is encoded in the genome of Arabidopsis thaliana." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O04582-1 |
probable non-inhibitory serpin-Z5 isoform 1 (Arabidopsis thaliana)
|
At-SERPIND1/iso:1
|
"A probable non-inhibitory serpin-Z5 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O04582-1." [PRO:DNx, UniProtKB:O04582]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P05546 |
heparin cofactor 2 (human)
|
hSERPIND1
|
"A heparin cofactor 2 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P05546]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P05546-1 |
heparin cofactor 2 isoform h1 (human)
|
hSERPIND1/iso:h1
|
"A heparin cofactor 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05546-1." [PRO:DNx, UniProtKB:P05546]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P05546-2 |
heparin cofactor 2 isoform h2 (human)
|
hSERPIND1/iso:h2
|
"A heparin cofactor 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05546-2." [PRO:DNx, UniProtKB:P05546]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049207 |
heparin cofactor 2, signal peptide removed form (human)
|
hSERPIND1/SigPep-
|
"A heparin cofactor 2 (human) that has had the signal peptide removed. UniProtKB:P05546, 20-499." [PRO:DNx, Reactome:R-HSA-5578885]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061494 |
heparin cofactor 2, signal peptide removed phosphorylated form (human)
|
hSERPIND1/SigPep-/PhosRes+
|
"A heparin cofactor 2 (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:P05546, 20-499, MOD:00696." [PRO:DNx, Reactome:R-HSA-8956982]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053545 |
heparin cofactor 2 N-glycosylated 1 (human)
|
hSERPIND1/NGlyco:1
|
"A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-188 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P05546-1, Asn-188, MOD:00160~GNO:G06247RL." [GlyGen:P05546-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053546 |
heparin cofactor 2 N-glycosylated 2 (human)
|
hSERPIND1/NGlyco:2
|
"A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-188 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P05546-1, Asn-188, MOD:00160~GNO:G59626AS." [GlyGen:P05546-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053547 |
heparin cofactor 2 N-glycosylated 3 (human)
|
hSERPIND1/NGlyco:3
|
"A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-49 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P05546-1, Asn-49, MOD:00160~GNO:G00912UN." [GlyGen:P05546-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053548 |
heparin cofactor 2 N-glycosylated 4 (human)
|
hSERPIND1/NGlyco:4
|
"A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-49 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P05546-1, Asn-49, MOD:00160~GNO:G06247RL." [GlyGen:P05546-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053549 |
heparin cofactor 2 N-glycosylated 5 (human)
|
hSERPIND1/NGlyco:5
|
"A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-49 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G41247ZX. Example: UniProtKB:P05546-1, Asn-49, MOD:00160~GNO:G41247ZX." [GlyGen:P05546-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053550 |
heparin cofactor 2 N-glycosylated 6 (human)
|
hSERPIND1/NGlyco:6
|
"A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-49 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P05546-1, Asn-49, MOD:00160~GNO:G59626AS." [GlyGen:P05546-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053551 |
heparin cofactor 2 N-glycosylated 7 (human)
|
hSERPIND1/NGlyco:7
|
"A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-49 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P05546-1, Asn-49, MOD:00160~GNO:G88374WZ." [GlyGen:P05546-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053552 |
heparin cofactor 2 N-glycosylated 8 (human)
|
hSERPIND1/NGlyco:8
|
"A heparin cofactor 2 (human) that has been N-glycosylated at the residue equivalent to Asn-49 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P05546-1, Asn-49, MOD:00160~GNO:G94917XT." [GlyGen:P05546-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053553 |
heparin cofactor 2 O-glycosylated 1 (human)
|
hSERPIND1/OGlyco:1
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Ser-100 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05546-1, Ser-100, MOD:00002~GNO:G43417UB." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053554 |
heparin cofactor 2 O-glycosylated 2 (human)
|
hSERPIND1/OGlyco:2
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Ser-102 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05546-1, Ser-102, MOD:00002~GNO:G43417UB." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053555 |
heparin cofactor 2 O-glycosylated 3 (human)
|
hSERPIND1/OGlyco:3
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Ser-102 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05546-1, Ser-102, MOD:00002~GNO:G53434XO." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053556 |
heparin cofactor 2 O-glycosylated 4 (human)
|
hSERPIND1/OGlyco:4
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Ser-37 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05546-1, Ser-37, MOD:00002~GNO:G43417UB." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053557 |
heparin cofactor 2 O-glycosylated 5 (human)
|
hSERPIND1/OGlyco:5
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Ser-51 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P05546-1, Ser-51, MOD:00002~GNO:G29068FM." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053558 |
heparin cofactor 2 O-glycosylated 6 (human)
|
hSERPIND1/OGlyco:6
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Ser-51 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05546-1, Ser-51, MOD:00002~GNO:G43417UB." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053559 |
heparin cofactor 2 O-glycosylated 7 (human)
|
hSERPIND1/OGlyco:7
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Thr-104 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P05546-1, Thr-104, MOD:00005~GNO:G29068FM." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053560 |
heparin cofactor 2 O-glycosylated 8 (human)
|
hSERPIND1/OGlyco:8
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Thr-104 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05546-1, Thr-104, MOD:00005~GNO:G43417UB." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053561 |
heparin cofactor 2 O-glycosylated 9 (human)
|
hSERPIND1/OGlyco:9
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Thr-453 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05546-1, Thr-453, MOD:00005~GNO:G43417UB." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053562 |
heparin cofactor 2 O-glycosylated 10 (human)
|
hSERPIND1/OGlyco:10
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Thr-454 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P05546-1, Thr-454, MOD:00005~GNO:G29068FM." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053563 |
heparin cofactor 2 O-glycosylated 11 (human)
|
hSERPIND1/OGlyco:11
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Thr-454 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05546-1, Thr-454, MOD:00005~GNO:G43417UB." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053564 |
heparin cofactor 2 O-glycosylated 12 (human)
|
hSERPIND1/OGlyco:12
|
"A heparin cofactor 2 (human) that has been O-glycosylated at the residue equivalent to Thr-457 of the amino acid sequence represented by UniProtKB:P05546-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05546-1, Thr-457, MOD:00005~GNO:G43417UB." [GlyGen:P05546-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000061494 |
heparin cofactor 2, signal peptide removed phosphorylated form (human)
|
hSERPIND1/SigPep-/PhosRes+
|
"A heparin cofactor 2 (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:P05546, 20-499, MOD:00696." [PRO:DNx, Reactome:R-HSA-8956982]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P49182 |
heparin cofactor 2 (mouse)
|
mSERPIND1
|
"A heparin cofactor 2 that is encoded in the genome of mouse." [OMA:P49182, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q64268 |
heparin cofactor 2 (rat)
|
rSERPIND1
|
"A heparin cofactor 2 that is encoded in the genome of rat." [OMA:Q64268, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021431 |
heparin cofactor 2, signal peptide removed form
|
SERPIND1/SigPep-
|
"A heparin cofactor 2 that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049207 |
heparin cofactor 2, signal peptide removed form (human)
|
hSERPIND1/SigPep-
|
"A heparin cofactor 2 (human) that has had the signal peptide removed. UniProtKB:P05546, 20-499." [PRO:DNx, Reactome:R-HSA-5578885]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061494 |
heparin cofactor 2, signal peptide removed phosphorylated form (human)
|
hSERPIND1/SigPep-/PhosRes+
|
"A heparin cofactor 2 (human) that has had the signal peptide removed and that includes at least one phosphorylated residue. UniProtKB:P05546, 20-499, MOD:00696." [PRO:DNx, Reactome:R-HSA-8956982]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014702 |
plasminogen activator inhibitor 1
|
SERPINE1
|
"A serpin that is a translation product of the human SERPINE1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P05121 |
plasminogen activator inhibitor 1 (human)
|
hSERPINE1
|
"A plasminogen activator inhibitor 1 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P05121]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P05121-1 |
plasminogen activator inhibitor 1 isoform 1 (human)
|
hSERPINE1/iso:1
|
"A plasminogen activator inhibitor 1 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P05121-2 |
plasminogen activator inhibitor 1 isoform h2 (human)
|
hSERPINE1/iso:h2
|
"A plasminogen activator inhibitor 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05121-2." [PRO:DNx, UniProtKB:P05121]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049208 |
plasminogen activator inhibitor 1, signal peptide removed form (human)
|
hSERPINE1/SigPep-
|
"A plasminogen activator inhibitor 1 (human) that has had the signal peptide removed. UniProtKB:P05121, 24-402." [PRO:DNx, Reactome:R-HSA-114649, Reactome:R-HSA-158922]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053452 |
plasminogen activator inhibitor 1 N-glycosylated 1 (human)
|
hSERPINE1/NGlyco:1
|
"A plasminogen activator inhibitor 1 (human) that has been N-glycosylated at the residue equivalent to Asn-288 of the amino acid sequence represented by UniProtKB:P05121-1, in which the glycan composition is represented by GlyTouCan:G07799LX. Example: UniProtKB:P05121-1, Asn-288, MOD:00160~GNO:G07799LX." [GlyGen:P05121-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053453 |
plasminogen activator inhibitor 1 N-glycosylated 2 (human)
|
hSERPINE1/NGlyco:2
|
"A plasminogen activator inhibitor 1 (human) that has been N-glycosylated at the residue equivalent to Asn-288 of the amino acid sequence represented by UniProtKB:P05121-1, in which the glycan composition is represented by GlyTouCan:G49955PK. Example: UniProtKB:P05121-1, Asn-288, MOD:00160~GNO:G49955PK." [GlyGen:P05121-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053454 |
plasminogen activator inhibitor 1 N-glycosylated 3 (human)
|
hSERPINE1/NGlyco:3
|
"A plasminogen activator inhibitor 1 (human) that has been N-glycosylated at the residue equivalent to Asn-288 of the amino acid sequence represented by UniProtKB:P05121-1, in which the glycan composition is represented by GlyTouCan:G72791KH. Example: UniProtKB:P05121-1, Asn-288, MOD:00160~GNO:G72791KH." [GlyGen:P05121-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053455 |
plasminogen activator inhibitor 1 N-glycosylated 4 (human)
|
hSERPINE1/NGlyco:4
|
"A plasminogen activator inhibitor 1 (human) that has been N-glycosylated at the residue equivalent to Asn-288 of the amino acid sequence represented by UniProtKB:P05121-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P05121-1, Asn-288, MOD:00160~GNO:G88374WZ." [GlyGen:P05121-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053456 |
plasminogen activator inhibitor 1 O-glycosylated 1 (human)
|
hSERPINE1/OGlyco:1
|
"A plasminogen activator inhibitor 1 (human) that has been O-glycosylated at the residue equivalent to Ser-359 of the amino acid sequence represented by UniProtKB:P05121-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P05121-1, Ser-359, MOD:00002~GNO:G29068FM." [GlyGen:P05121-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053457 |
plasminogen activator inhibitor 1 O-glycosylated 2 (human)
|
hSERPINE1/OGlyco:2
|
"A plasminogen activator inhibitor 1 (human) that has been O-glycosylated at the residue equivalent to Ser-359 of the amino acid sequence represented by UniProtKB:P05121-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05121-1, Ser-359, MOD:00002~GNO:G43417UB." [GlyGen:P05121-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053458 |
plasminogen activator inhibitor 1 O-glycosylated 3 (human)
|
hSERPINE1/OGlyco:3
|
"A plasminogen activator inhibitor 1 (human) that has been O-glycosylated at the residue equivalent to Ser-360 of the amino acid sequence represented by UniProtKB:P05121-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05121-1, Ser-360, MOD:00002~GNO:G43417UB." [GlyGen:P05121-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053459 |
plasminogen activator inhibitor 1 O-glycosylated 4 (human)
|
hSERPINE1/OGlyco:4
|
"A plasminogen activator inhibitor 1 (human) that has been O-glycosylated at the residue equivalent to Thr-362 of the amino acid sequence represented by UniProtKB:P05121-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05121-1, Thr-362, MOD:00005~GNO:G43417UB." [GlyGen:P05121-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000073718 |
plasminogen activator inhibitor 1 phosphorylated 1 (human)
|
hSERPINE1/Phos:1
|
"A plasminogen activator inhibitor 1 (human) that has been phosphorylated on the residue at the position equivalent to Thr-72 of the amino acid sequence represented by UniProtKB:P05121-1. Example: UniProtKB:P05121-1, Thr-72, MOD:00047." [IEDB_epitope:2146787, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000085270 |
plasminogen activator inhibitor 1 methylated 1 (human)
|
hSERPINE1/Me:1
|
"A plasminogen activator inhibitor 1 (human) that has been methylated on the residue at the position equivalent to Cys-9 of the amino acid sequence represented by UniProtKB:P05121-1. Example: UniProtKB:P05121-1, Cys-9, MOD:00660." [IEDB_epitope:1038751, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000085521 |
plasminogen activator inhibitor 1 cysteinylated 1 (human)
|
hSERPINE1/Cyst:1
|
"A plasminogen activator inhibitor 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-9 of the amino acid sequence represented by UniProtKB:P05121-1. Example: UniProtKB:P05121-1, Cys-9, MOD:00765." [IEDB_epitope:1038750, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P20961 |
plasminogen activator inhibitor 1 (rat)
|
rSERPINE1
|
"A plasminogen activator inhibitor 1 that is encoded in the genome of rat." [OMA:P20961, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P20961-1 |
plasminogen activator inhibitor 1 isoform 1 (rat)
|
rSERPINE1/iso:1
|
"A plasminogen activator inhibitor 1 isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P22777 |
plasminogen activator inhibitor 1 (mouse)
|
mSERPINE1
|
"A plasminogen activator inhibitor 1 that is encoded in the genome of mouse." [OMA:P22777, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000038665 |
plasminogen activator inhibitor 1 isoform 1
|
SERPINE1/iso:1
|
"A plasminogen activator inhibitor 1 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05121-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P05121-1 |
plasminogen activator inhibitor 1 isoform 1 (human)
|
hSERPINE1/iso:1
|
"A plasminogen activator inhibitor 1 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P20961-1 |
plasminogen activator inhibitor 1 isoform 1 (rat)
|
rSERPINE1/iso:1
|
"A plasminogen activator inhibitor 1 isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021433 |
plasminogen activator inhibitor 1, signal peptide removed form
|
SERPINE1/SigPep-
|
"A plasminogen activator inhibitor 1 that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049208 |
plasminogen activator inhibitor 1, signal peptide removed form (human)
|
hSERPINE1/SigPep-
|
"A plasminogen activator inhibitor 1 (human) that has had the signal peptide removed. UniProtKB:P05121, 24-402." [PRO:DNx, Reactome:R-HSA-114649, Reactome:R-HSA-158922]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014703 |
glia-derived nexin
|
SERPINE2
|
"A serpin that is a translation product of the human SERPINE2 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P07092 |
glia-derived nexin (rat)
|
rSERPINE2
|
"A glia-derived nexin that is encoded in the genome of rat." [OMA:P07092, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P07093 |
glia-derived nexin (human)
|
hSERPINE2
|
"A glia-derived nexin that is encoded in the genome of human." [PRO:CNA, UniProtKB:P07093]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P07093-1 |
glia-derived nexin isoform h1 (human)
|
hSERPINE2/iso:h1
|
"A glia-derived nexin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P07093-1." [PRO:DNx, UniProtKB:P07093]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P07093-2 |
glia-derived nexin isoform h2 (human)
|
hSERPINE2/iso:h2
|
"A glia-derived nexin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P07093-2." [PRO:DNx, UniProtKB:P07093]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P07093-3 |
glia-derived nexin isoform h3 (human)
|
hSERPINE2/iso:h3
|
"A glia-derived nexin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P07093-3." [PRO:DNx, UniProtKB:P07093]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049209 |
glia-derived nexin, signal peptide removed form (human)
|
hSERPINE2/SigPep-
|
"A glia-derived nexin (human) that has had the signal peptide removed. UniProtKB:P07093, 20-398." [PRO:DNx, Reactome:R-HSA-4127459, Reactome:R-HSA-4127461]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053641 |
glia-derived nexin O-glycosylated 1 (human)
|
hSERPINE2/OGlyco:1
|
"A glia-derived nexin (human) that has been O-glycosylated at the residue equivalent to Thr-359 of the amino acid sequence represented by UniProtKB:P07093-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P07093-1, Thr-359, MOD:00005~GNO:G43417UB." [GlyGen:P07093-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000076772 |
glia-derived nexin deaminated 1 (human)
|
hSERPINE2/Deam:1
|
"A glia-derived nexin (human) that has been deaminated on the residue at the position equivalent to Asn-33 of the amino acid sequence represented by UniProtKB:P07093-1. Example: UniProtKB:P07093-1, Asn-33, MOD:00684." [IEDB_epitope:1986605, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000079593 |
glia-derived nexin deaminated 2 (human)
|
hSERPINE2/Deam:2
|
"A glia-derived nexin (human) that has been deaminated on the residue at the position equivalent to Gln-290 of the amino acid sequence represented by UniProtKB:P07093-1. Example: UniProtKB:P07093-1, Gln-290, MOD:00685." [IEDB_epitope:932498, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000085254 |
glia-derived nexin N-glycosylated 1 (human)
|
hSERPINE2/NGlyco:1
|
"A glia-derived nexin (human) that has been N-glycosylated on the residue at the position equivalent to Asn-118 of the amino acid sequence represented by UniProtKB:P07093-1. Example: UniProtKB:P07093-1, Asn-118, MOD:00160." [IEDB_epitope:591998, IEDB_epitope:592485, IEDB_epitope:592486, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q07235 |
glia-derived nexin (mouse)
|
mSERPINE2
|
"A glia-derived nexin that is encoded in the genome of mouse." [OMA:Q07235, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021435 |
glia-derived nexin, signal peptide removed form
|
SERPINE2/SigPep-
|
"A glia-derived nexin that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049209 |
glia-derived nexin, signal peptide removed form (human)
|
hSERPINE2/SigPep-
|
"A glia-derived nexin (human) that has had the signal peptide removed. UniProtKB:P07093, 20-398." [PRO:DNx, Reactome:R-HSA-4127459, Reactome:R-HSA-4127461]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014704 |
serpin E3
|
SERPINE3
|
"A serpin that is a translation product of the human SERPINE3 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:A8MV23 |
serpin E3 (human)
|
hSERPINE3
|
"A serpin E3 that is encoded in the genome of human." [PRO:CNA, UniProtKB:A8MV23]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:A8MV23-1 |
serpin E3 isoform h1 (human)
|
hSERPINE3/iso:h1
|
"A serpin E3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MV23-1." [PRO:DNx, UniProtKB:A8MV23]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:A8MV23-2 |
serpin E3 isoform h2 (human)
|
hSERPINE3/iso:h2
|
"A serpin E3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MV23-2." [PRO:DNx, UniProtKB:A8MV23]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:B0UYL8 |
probable serpin E3 (zebrafish)
|
z-SERPINE3
|
"A serpin E3 that is encoded in the genome of zebrafish." [OMA:B0UYL8, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014705 |
pigment epithelium-derived factor
|
SERPINF1
|
"A serpin that is a translation product of the human SERPINF1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P36955 |
pigment epithelium-derived factor (human)
|
hSERPINF1
|
"A pigment epithelium-derived factor that is encoded in the genome of human." [PRO:CNA, UniProtKB:P36955]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056415 |
pigment epithelium-derived factor O-glycosylated 1 (human)
|
hSERPINF1/OGlyco:1
|
"A pigment epithelium-derived factor (human) that has been O-glycosylated at the residue equivalent to Ser-24 of the amino acid sequence represented by UniProtKB:P36955-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P36955-1, Ser-24, MOD:00002~GNO:G43417UB." [GlyGen:P36955-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056416 |
pigment epithelium-derived factor O-glycosylated 2 (human)
|
hSERPINF1/OGlyco:2
|
"A pigment epithelium-derived factor (human) that has been O-glycosylated at the residue equivalent to Ser-30 of the amino acid sequence represented by UniProtKB:P36955-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P36955-1, Ser-30, MOD:00002~GNO:G29068FM." [GlyGen:P36955-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056417 |
pigment epithelium-derived factor O-glycosylated 3 (human)
|
hSERPINF1/OGlyco:3
|
"A pigment epithelium-derived factor (human) that has been O-glycosylated at the residue equivalent to Ser-30 of the amino acid sequence represented by UniProtKB:P36955-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P36955-1, Ser-30, MOD:00002~GNO:G43417UB." [GlyGen:P36955-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056418 |
pigment epithelium-derived factor O-glycosylated 4 (human)
|
hSERPINF1/OGlyco:4
|
"A pigment epithelium-derived factor (human) that has been O-glycosylated at the residue equivalent to Ser-374 of the amino acid sequence represented by UniProtKB:P36955-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P36955-1, Ser-374, MOD:00002~GNO:G43417UB." [GlyGen:P36955-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056419 |
pigment epithelium-derived factor O-glycosylated 5 (human)
|
hSERPINF1/OGlyco:5
|
"A pigment epithelium-derived factor (human) that has been O-glycosylated at the residue equivalent to Thr-36 of the amino acid sequence represented by UniProtKB:P36955-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P36955-1, Thr-36, MOD:00005~GNO:G29068FM." [GlyGen:P36955-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056420 |
pigment epithelium-derived factor O-glycosylated 6 (human)
|
hSERPINF1/OGlyco:6
|
"A pigment epithelium-derived factor (human) that has been O-glycosylated at the residue equivalent to Thr-36 of the amino acid sequence represented by UniProtKB:P36955-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P36955-1, Thr-36, MOD:00005~GNO:G43417UB." [GlyGen:P36955-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056421 |
pigment epithelium-derived factor O-glycosylated 7 (human)
|
hSERPINF1/OGlyco:7
|
"A pigment epithelium-derived factor (human) that has been O-glycosylated at the residue equivalent to Thr-372 of the amino acid sequence represented by UniProtKB:P36955-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P36955-1, Thr-372, MOD:00005~GNO:G29068FM." [GlyGen:P36955-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056422 |
pigment epithelium-derived factor O-glycosylated 8 (human)
|
hSERPINF1/OGlyco:8
|
"A pigment epithelium-derived factor (human) that has been O-glycosylated at the residue equivalent to Thr-372 of the amino acid sequence represented by UniProtKB:P36955-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P36955-1, Thr-372, MOD:00005~GNO:G43417UB." [GlyGen:P36955-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000072515 |
pigment epithelium-derived factor cysteinylated 1 (human)
|
hSERPINF1/Cyst:1
|
"A pigment epithelium-derived factor (human) that has been cysteinylated on the residue at the position equivalent to Cys-261 of the amino acid sequence represented by UniProtKB:P36955. UniProtKB:P36955, Cys-261, MOD:00765." [IEDB_epitope:2124581, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000076761 |
pigment epithelium-derived factor phosphorylated 1 (human)
|
hSERPINF1/Phos:1
|
"A pigment epithelium-derived factor (human) that has been phosphorylated on the residue at the position equivalent to Thr-170 of the amino acid sequence represented by UniProtKB:P36955. UniProtKB:P36955, Thr-170, MOD:00047." [IEDB_epitope:2149338, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P97298 |
pigment epithelium-derived factor (mouse)
|
mSERPINF1
|
"A pigment epithelium-derived factor that is encoded in the genome of mouse." [OMA:P97298, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q95121 |
pigment epithelium-derived factor (cow)
|
cow-SERPINF1
|
"A pigment epithelium-derived factor that is encoded in the genome of cow." [OMA:Q95121, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021437 |
pigment epithelium-derived factor, signal peptide removed form
|
SERPINF1/SigPep-
|
"A pigment epithelium-derived factor that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014706 |
alpha-2-antiplasmin
|
SERPINF2
|
"A serpin that is a translation product of the human SERPINF2 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P08697 |
alpha-2-antiplasmin (human)
|
hSERPINF2
|
"An alpha-2-antiplasmin that is encoded in the genome of human." [PRO:CNA, UniProtKB:P08697]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P08697-1 |
alpha-2-antiplasmin isoform h1 (human)
|
hSERPINF2/iso:h1
|
"An alpha-2-antiplasmin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P08697-1." [PRO:DNx, UniProtKB:P08697]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P08697-2 |
alpha-2-antiplasmin isoform h2 (human)
|
hSERPINF2/iso:h2
|
"An alpha-2-antiplasmin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P08697-2." [PRO:DNx, UniProtKB:P08697]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054553 |
alpha-2-antiplasmin N-glycosylated 1 (human)
|
hSERPINF2/NGlyco:1
|
"An alpha-2-antiplasmin (human) that has been N-glycosylated at the residue equivalent to Asn-126 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P08697-1, Asn-126, MOD:00160~GNO:G00912UN." [GlyGen:P08697-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054554 |
alpha-2-antiplasmin N-glycosylated 2 (human)
|
hSERPINF2/NGlyco:2
|
"An alpha-2-antiplasmin (human) that has been N-glycosylated at the residue equivalent to Asn-126 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P08697-1, Asn-126, MOD:00160~GNO:G06247RL." [GlyGen:P08697-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054555 |
alpha-2-antiplasmin O-glycosylated 1 (human)
|
hSERPINF2/OGlyco:1
|
"An alpha-2-antiplasmin (human) that has been O-glycosylated at the residue equivalent to Ser-37 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P08697-1, Ser-37, MOD:00002~GNO:G43417UB." [GlyGen:P08697-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054556 |
alpha-2-antiplasmin O-glycosylated 2 (human)
|
hSERPINF2/OGlyco:2
|
"An alpha-2-antiplasmin (human) that has been O-glycosylated at the residue equivalent to Ser-45 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P08697-1, Ser-45, MOD:00002~GNO:G29068FM." [GlyGen:P08697-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054557 |
alpha-2-antiplasmin O-glycosylated 3 (human)
|
hSERPINF2/OGlyco:3
|
"An alpha-2-antiplasmin (human) that has been O-glycosylated at the residue equivalent to Ser-45 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P08697-1, Ser-45, MOD:00002~GNO:G43417UB." [GlyGen:P08697-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054558 |
alpha-2-antiplasmin O-glycosylated 4 (human)
|
hSERPINF2/OGlyco:4
|
"An alpha-2-antiplasmin (human) that has been O-glycosylated at the residue equivalent to Thr-36 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P08697-1, Thr-36, MOD:00005~GNO:G29068FM." [GlyGen:P08697-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054559 |
alpha-2-antiplasmin O-glycosylated 5 (human)
|
hSERPINF2/OGlyco:5
|
"An alpha-2-antiplasmin (human) that has been O-glycosylated at the residue equivalent to Thr-36 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P08697-1, Thr-36, MOD:00005~GNO:G43417UB." [GlyGen:P08697-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054560 |
alpha-2-antiplasmin O-glycosylated 6 (human)
|
hSERPINF2/OGlyco:6
|
"An alpha-2-antiplasmin (human) that has been O-glycosylated at the residue equivalent to Thr-36 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P08697-1, Thr-36, MOD:00005~GNO:G53434XO." [GlyGen:P08697-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054561 |
alpha-2-antiplasmin O-glycosylated 7 (human)
|
hSERPINF2/OGlyco:7
|
"An alpha-2-antiplasmin (human) that has been O-glycosylated at the residue equivalent to Thr-397 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P08697-1, Thr-397, MOD:00005~GNO:G29068FM." [GlyGen:P08697-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000054562 |
alpha-2-antiplasmin O-glycosylated 8 (human)
|
hSERPINF2/OGlyco:8
|
"An alpha-2-antiplasmin (human) that has been O-glycosylated at the residue equivalent to Thr-397 of the amino acid sequence represented by UniProtKB:P08697-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P08697-1, Thr-397, MOD:00005~GNO:G43417UB." [GlyGen:P08697-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000071290 |
alpha-2-antiplasmin, mature form (human)
|
hSERPINF2/mature
|
"An alpha-2-antiplasmin (human) that has had the signal peptide and propeptide removed. Example: UniProtKB:P08697-1, 40-491." [PRO:DNx, Reactome:R-HSA-141759, Reactome:R-HSA-141760]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q61247 |
alpha-2-antiplasmin (mouse)
|
mSERPINF2
|
"An alpha-2-antiplasmin that is encoded in the genome of mouse." [OMA:Q61247, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021439 |
alpha-2-antiplasmin, signal peptide removed form
|
SERPINF2/SigPep-
|
"An alpha-2-antiplasmin that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000071290 |
alpha-2-antiplasmin, mature form (human)
|
hSERPINF2/mature
|
"An alpha-2-antiplasmin (human) that has had the signal peptide and propeptide removed. Example: UniProtKB:P08697-1, 40-491." [PRO:DNx, Reactome:R-HSA-141759, Reactome:R-HSA-141760]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021440 |
alpha-2-antiplasmin proteolytic cleavage product
|
SERPINF2/ClvPrd
|
"An alpha-2-antiplasmin that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014707 |
plasma protease C1 inhibitor
|
SERPING1
|
"A serpin that is a translation product of the human SERPING1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P05155 |
plasma protease C1 inhibitor (human)
|
hSERPING1
|
"A plasma protease C1 inhibitor that is encoded in the genome of human." [PRO:CNA, UniProtKB:P05155]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P05155-1 |
plasma protease C1 inhibitor isoform h1 (human)
|
hSERPING1/iso:h1
|
"A plasma protease C1 inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05155-1." [PRO:DNx, UniProtKB:P05155]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P05155-2 |
plasma protease C1 inhibitor isoform h2 (human)
|
hSERPING1/iso:h2
|
"A plasma protease C1 inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05155-2." [PRO:DNx, UniProtKB:P05155]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P05155-3 |
plasma protease C1 inhibitor isoform h3 (human)
|
hSERPING1/iso:h3
|
"A plasma protease C1 inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P05155-3." [PRO:DNx, UniProtKB:P05155]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049210 |
plasma protease C1 inhibitor, signal peptide removed form (human)
|
hSERPING1/SigPep-
|
"A plasma protease C1 inhibitor (human) that has had the signal peptide removed. UniProtKB:P05155, 23-500." [PRO:DNx, Reactome:R-HSA-139868, Reactome:R-HSA-158296]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060388 |
plasma protease C1 inhibitor sequence variant L177P, signal peptide removed form (human)
|
hSERPING1/var:L177P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Leu-177 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-177, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650574]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060408 |
plasma protease C1 inhibitor sequence variant A456E, signal peptide removed form (human)
|
hSERPING1/var:A456E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Ala-456 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-456, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650569]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060429 |
plasma protease C1 inhibitor sequence variant Q338*, signal peptide removed form (human)
|
hSERPING1/var:Q338*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asp-337 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-337." [PRO:DNx, Reactome:R-HSA-9651424]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060501 |
plasma protease C1 inhibitor sequence variant V288E, signal peptide removed form (human)
|
hSERPING1/var:V288E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Val-288 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Val-288, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650415]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060546 |
plasma protease C1 inhibitor sequence variant I462S, signal peptide removed form (human)
|
hSERPING1/var:I462S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Ile-462 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ile-462, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650446]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060778 |
plasma protease C1 inhibitor sequence variant F225*, signal peptide removed form (human)
|
hSERPING1/var:F225*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Ile-224 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-224." [PRO:DNx, Reactome:R-HSA-9651381]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060960 |
plasma protease C1 inhibitor sequence variant V473M, signal peptide removed form (human)
|
hSERPING1/var:V473M/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Met residue at the position equivalent to Val-473 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Val-473, CHEBI:16044." [PRO:DNx, Reactome:R-HSA-9650331]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061036 |
plasma protease C1 inhibitor sequence variant T467P, signal peptide removed form (human)
|
hSERPING1/var:T467P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Thr-467 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Thr-467, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650562]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061104 |
plasma protease C1 inhibitor sequence variant Q484*, signal peptide removed form (human)
|
hSERPING1/var:Q484*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asp-483 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-483." [PRO:DNx, Reactome:R-HSA-9650410]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061229 |
plasma protease C1 inhibitor sequence variant G493R, signal peptide removed form (human)
|
hSERPING1/var:G493R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-493, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650561]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061277 |
plasma protease C1 inhibitor sequence variant L481R, signal peptide removed form (human)
|
hSERPING1/var:L481R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-481, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9651451]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061318 |
plasma protease C1 inhibitor sequence variant A458V, signal peptide removed form (human)
|
hSERPING1/var:A458V/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Val residue at the position equivalent to Ala-458 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-458, CHEBI:30015." [PRO:DNx, Reactome:R-HSA-9650402]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061510 |
plasma protease C1 inhibitor sequence variant I196N, signal peptide removed form (human)
|
hSERPING1/var:I196N/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Asn residue at the position equivalent to Ile-196 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ile-196, CHEBI:50347." [PRO:DNx, Reactome:R-HSA-9651390]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061553 |
plasma protease C1 inhibitor sequence variant Y496*, signal peptide removed form (human)
|
hSERPING1/var:Y496*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Val-495 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-495." [PRO:DNx, Reactome:R-HSA-9650355]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061573 |
plasma protease C1 inhibitor sequence variant N291H, signal peptide removed form (human)
|
hSERPING1/var:N291H/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a His residue at the position equivalent to Asn-291 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Asn-291, CHEBI:29979." [PRO:DNx, Reactome:R-HSA-9650545]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061585 |
plasma protease C1 inhibitor sequence variant P476L, signal peptide removed form (human)
|
hSERPING1/var:P476L/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Leu residue at the position equivalent to Pro-476 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-476, CHEBI:30006." [PRO:DNx, Reactome:R-HSA-9650563]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061662 |
plasma protease C1 inhibitor sequence variant G184R, signal peptide removed form (human)
|
hSERPING1/var:G184R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-184 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-184, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650424]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061680 |
plasma protease C1 inhibitor sequence variant P498R, signal peptide removed form (human)
|
hSERPING1/var:P498R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Pro-498 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-498, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650544]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061855 |
plasma protease C1 inhibitor sequence variant F236S, signal peptide removed form (human)
|
hSERPING1/var:F236S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Phe-236 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Phe-236, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650538]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061929 |
plasma protease C1 inhibitor sequence variant R466C, signal peptide removed form (human)
|
hSERPING1/var:R466C/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Cys residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29950." [PRO:DNx, Reactome:R-HSA-9650553]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062268 |
plasma protease C1 inhibitor sequence variant R466S, signal peptide removed form (human)
|
hSERPING1/var:R466S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650572]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062279 |
plasma protease C1 inhibitor sequence variant A458T, signal peptide removed form (human)
|
hSERPING1/var:A458T/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Thr residue at the position equivalent to Ala-458 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-458, CHEBI:30013." [PRO:DNx, Reactome:R-HSA-9650554]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062324 |
plasma protease C1 inhibitor sequence variant W482*, signal peptide removed form (human)
|
hSERPING1/var:W482*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-481." [PRO:DNx, Reactome:R-HSA-9650502]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062491 |
plasma protease C1 inhibitor sequence variant P498S, signal peptide removed form (human)
|
hSERPING1/var:P498S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Pro-498 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-498, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650568]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062550 |
plasma protease C1 inhibitor sequence variant G345R, signal peptide removed form (human)
|
hSERPING1/var:G345R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-345 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-345, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9651385]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062579 |
plasma protease C1 inhibitor sequence variant R494*, signal peptide removed form (human)
|
hSERPING1/var:R494*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-493." [PRO:DNx, Reactome:R-HSA-9650555]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062615 |
plasma protease C1 inhibitor sequence variant Q474*, signal peptide removed form (human)
|
hSERPING1/var:Q474*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Val-473 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-473." [PRO:DNx, Reactome:R-HSA-9650547]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062857 |
plasma protease C1 inhibitor sequence variant L481P, signal peptide removed form (human)
|
hSERPING1/var:L481P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-481, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9651448]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063441 |
plasma protease C1 inhibitor sequence variant P489R, signal peptide removed form (human)
|
hSERPING1/var:P489R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Pro-489 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-489, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650330]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063530 |
plasma protease C1 inhibitor sequence variant R400C, signal peptide removed form (human)
|
hSERPING1/var:R400C/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Cys residue at the position equivalent to Arg-400 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-400, CHEBI:29950." [PRO:DNx, Reactome:R-HSA-9650511]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063553 |
plasma protease C1 inhibitor sequence variant S318*, signal peptide removed form (human)
|
hSERPING1/var:S318*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asn-317 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-317." [PRO:DNx, Reactome:R-HSA-9651387]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063798 |
plasma protease C1 inhibitor sequence variant T189N, signal peptide removed form (human)
|
hSERPING1/var:T189N/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Asn residue at the position equivalent to Thr-189 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Thr-189, CHEBI:50347." [PRO:DNx, Reactome:R-HSA-9650346]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063908 |
plasma protease C1 inhibitor sequence variant S170P, signal peptide removed form (human)
|
hSERPING1/var:S170P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Ser-170 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ser-170, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650362]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064158 |
plasma protease C1 inhibitor sequence variant G493E, signal peptide removed form (human)
|
hSERPING1/var:G493E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-493, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650548]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064313 |
plasma protease C1 inhibitor sequence variant G184E, signal peptide removed form (human)
|
hSERPING1/var:G184E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Gly-184 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-184, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650527]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064435 |
plasma protease C1 inhibitor sequence variant R466H, signal peptide removed form (human)
|
hSERPING1/var:R466H/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a His residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29979." [PRO:DNx, Reactome:R-HSA-9650560]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064491 |
plasma protease C1 inhibitor sequence variant R466L, signal peptide removed form (human)
|
hSERPING1/var:R466L/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Leu residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:30006." [PRO:DNx, Reactome:R-HSA-9650436]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053466 |
plasma protease C1 inhibitor N-glycosylated 1 (human)
|
hSERPING1/NGlyco:1
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G00912UN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053467 |
plasma protease C1 inhibitor N-glycosylated 2 (human)
|
hSERPING1/NGlyco:2
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G08293MJ." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053468 |
plasma protease C1 inhibitor N-glycosylated 3 (human)
|
hSERPING1/NGlyco:3
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G12580WI." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053469 |
plasma protease C1 inhibitor N-glycosylated 4 (human)
|
hSERPING1/NGlyco:4
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G42358LZ." [GlyGen:P05155-1, PMID:24279413, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053470 |
plasma protease C1 inhibitor N-glycosylated 5 (human)
|
hSERPING1/NGlyco:5
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G59626AS." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053471 |
plasma protease C1 inhibitor N-glycosylated 6 (human)
|
hSERPING1/NGlyco:6
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-238 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G85740DB. Example: UniProtKB:P05155-1, Asn-238, MOD:00160~GNO:G85740DB." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053472 |
plasma protease C1 inhibitor N-glycosylated 7 (human)
|
hSERPING1/NGlyco:7
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G00912UN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053473 |
plasma protease C1 inhibitor N-glycosylated 8 (human)
|
hSERPING1/NGlyco:8
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G06247RL." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053474 |
plasma protease C1 inhibitor N-glycosylated 9 (human)
|
hSERPING1/NGlyco:9
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G08293MJ." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053475 |
plasma protease C1 inhibitor N-glycosylated 10 (human)
|
hSERPING1/NGlyco:10
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G10486CT." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053476 |
plasma protease C1 inhibitor N-glycosylated 11 (human)
|
hSERPING1/NGlyco:11
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G12580WI." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053477 |
plasma protease C1 inhibitor N-glycosylated 12 (human)
|
hSERPING1/NGlyco:12
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G27947YN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053478 |
plasma protease C1 inhibitor N-glycosylated 13 (human)
|
hSERPING1/NGlyco:13
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G36670VW. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G36670VW." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053479 |
plasma protease C1 inhibitor N-glycosylated 14 (human)
|
hSERPING1/NGlyco:14
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G43417UB." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053480 |
plasma protease C1 inhibitor N-glycosylated 15 (human)
|
hSERPING1/NGlyco:15
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G59626AS." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053481 |
plasma protease C1 inhibitor N-glycosylated 16 (human)
|
hSERPING1/NGlyco:16
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G85144OK." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053482 |
plasma protease C1 inhibitor N-glycosylated 17 (human)
|
hSERPING1/NGlyco:17
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G88374WZ." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053483 |
plasma protease C1 inhibitor N-glycosylated 18 (human)
|
hSERPING1/NGlyco:18
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P05155-1, Asn-253, MOD:00160~GNO:G00912UN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053484 |
plasma protease C1 inhibitor N-glycosylated 19 (human)
|
hSERPING1/NGlyco:19
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P05155-1, Asn-253, MOD:00160~GNO:G06247RL." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053485 |
plasma protease C1 inhibitor N-glycosylated 20 (human)
|
hSERPING1/NGlyco:20
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P05155-1, Asn-253, MOD:00160~GNO:G88374WZ." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053486 |
plasma protease C1 inhibitor N-glycosylated 21 (human)
|
hSERPING1/NGlyco:21
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P05155-1, Asn-253, MOD:00160~GNO:G94917XT." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053487 |
plasma protease C1 inhibitor N-glycosylated 22 (human)
|
hSERPING1/NGlyco:22
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-69 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G11115RO. Example: UniProtKB:P05155-1, Asn-69, MOD:00160~GNO:G11115RO." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053488 |
plasma protease C1 inhibitor N-glycosylated 23 (human)
|
hSERPING1/NGlyco:23
|
"A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-69 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P05155-1, Asn-69, MOD:00160~GNO:G27947YN." [GlyGen:P05155-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053489 |
plasma protease C1 inhibitor O-glycosylated 1 (human)
|
hSERPING1/OGlyco:1
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-113 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Ser-113, MOD:00002~GNO:G53434XO." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053490 |
plasma protease C1 inhibitor O-glycosylated 2 (human)
|
hSERPING1/OGlyco:2
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-28 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Ser-28, MOD:00002~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053491 |
plasma protease C1 inhibitor O-glycosylated 3 (human)
|
hSERPING1/OGlyco:3
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-28 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P05155-1, Ser-28, MOD:00002~GNO:G58001LT." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053492 |
plasma protease C1 inhibitor O-glycosylated 4 (human)
|
hSERPING1/OGlyco:4
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-30 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Ser-30, MOD:00002~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053493 |
plasma protease C1 inhibitor O-glycosylated 5 (human)
|
hSERPING1/OGlyco:5
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-31 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G36670VW. Example: UniProtKB:P05155-1, Ser-31, MOD:00002~GNO:G36670VW." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053494 |
plasma protease C1 inhibitor O-glycosylated 6 (human)
|
hSERPING1/OGlyco:6
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Ser-31 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Ser-31, MOD:00002~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053495 |
plasma protease C1 inhibitor O-glycosylated 7 (human)
|
hSERPING1/OGlyco:7
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-115 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-115, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053496 |
plasma protease C1 inhibitor O-glycosylated 8 (human)
|
hSERPING1/OGlyco:8
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-118 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-118, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053497 |
plasma protease C1 inhibitor O-glycosylated 9 (human)
|
hSERPING1/OGlyco:9
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-118 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Thr-118, MOD:00005~GNO:G53434XO." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053498 |
plasma protease C1 inhibitor O-glycosylated 10 (human)
|
hSERPING1/OGlyco:10
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-119 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-119, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053499 |
plasma protease C1 inhibitor O-glycosylated 11 (human)
|
hSERPING1/OGlyco:11
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-27 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P05155-1, Thr-27, MOD:00005~GNO:G29068FM." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053500 |
plasma protease C1 inhibitor O-glycosylated 12 (human)
|
hSERPING1/OGlyco:12
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-27 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-27, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053501 |
plasma protease C1 inhibitor O-glycosylated 13 (human)
|
hSERPING1/OGlyco:13
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-27 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Thr-27, MOD:00005~GNO:G53434XO." [GlyGen:P05155-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053502 |
plasma protease C1 inhibitor O-glycosylated 14 (human)
|
hSERPING1/OGlyco:14
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-47 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-47, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053503 |
plasma protease C1 inhibitor O-glycosylated 15 (human)
|
hSERPING1/OGlyco:15
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-47 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Thr-47, MOD:00005~GNO:G53434XO." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053504 |
plasma protease C1 inhibitor O-glycosylated 16 (human)
|
hSERPING1/OGlyco:16
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-48 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Thr-48, MOD:00005~GNO:G43417UB." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000053505 |
plasma protease C1 inhibitor O-glycosylated 17 (human)
|
hSERPING1/OGlyco:17
|
"A plasma protease C1 inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-48 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P05155-1, Thr-48, MOD:00005~GNO:G53434XO." [GlyGen:P05155-1, PMID:22171320, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000070326 |
plasma protease C1 inhibitor deaminated 1 (human)
|
hSERPING1/Deam:1
|
"A plasma protease C1 inhibitor (human) that has been deaminated on the residue at the position equivalent to Asn-352 of the amino acid sequence represented by UniProtKB:P05155-1. Example: UniProtKB:P05155-1, Asn-352, MOD:00684." [IEDB_epitope:1994741, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P97290 |
plasma protease C1 inhibitor (mouse)
|
mSERPING1
|
"A plasma protease C1 inhibitor that is encoded in the genome of mouse." [OMA:P97290, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P97290-1 |
plasma protease C1 inhibitor isoform 1 (mouse)
|
mSERPING1/iso:1
|
"A plasma protease C1 inhibitor isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q6P734 |
plasma protease C1 inhibitor (rat)
|
rSERPING1
|
"A plasma protease C1 inhibitor that is encoded in the genome of rat." [OMA:Q6P734, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q6P734-1 |
plasma protease C1 inhibitor isoform 1 (rat)
|
rSERPING1/iso:1
|
"A plasma protease C1 inhibitor isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000040182 |
plasma protease C1 inhibitor isoform 1
|
SERPING1/iso:1
|
"A plasma protease C1 inhibitor that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P97290-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P97290-1 |
plasma protease C1 inhibitor isoform 1 (mouse)
|
mSERPING1/iso:1
|
"A plasma protease C1 inhibitor isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q6P734-1 |
plasma protease C1 inhibitor isoform 1 (rat)
|
rSERPING1/iso:1
|
"A plasma protease C1 inhibitor isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021442 |
plasma protease C1 inhibitor, signal peptide removed form
|
SERPING1/SigPep-
|
"A plasma protease C1 inhibitor that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049210 |
plasma protease C1 inhibitor, signal peptide removed form (human)
|
hSERPING1/SigPep-
|
"A plasma protease C1 inhibitor (human) that has had the signal peptide removed. UniProtKB:P05155, 23-500." [PRO:DNx, Reactome:R-HSA-139868, Reactome:R-HSA-158296]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060388 |
plasma protease C1 inhibitor sequence variant L177P, signal peptide removed form (human)
|
hSERPING1/var:L177P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Leu-177 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-177, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650574]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060408 |
plasma protease C1 inhibitor sequence variant A456E, signal peptide removed form (human)
|
hSERPING1/var:A456E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Ala-456 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-456, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650569]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060429 |
plasma protease C1 inhibitor sequence variant Q338*, signal peptide removed form (human)
|
hSERPING1/var:Q338*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asp-337 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-337." [PRO:DNx, Reactome:R-HSA-9651424]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060501 |
plasma protease C1 inhibitor sequence variant V288E, signal peptide removed form (human)
|
hSERPING1/var:V288E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Val-288 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Val-288, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650415]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060546 |
plasma protease C1 inhibitor sequence variant I462S, signal peptide removed form (human)
|
hSERPING1/var:I462S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Ile-462 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ile-462, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650446]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060778 |
plasma protease C1 inhibitor sequence variant F225*, signal peptide removed form (human)
|
hSERPING1/var:F225*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Ile-224 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-224." [PRO:DNx, Reactome:R-HSA-9651381]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000060960 |
plasma protease C1 inhibitor sequence variant V473M, signal peptide removed form (human)
|
hSERPING1/var:V473M/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Met residue at the position equivalent to Val-473 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Val-473, CHEBI:16044." [PRO:DNx, Reactome:R-HSA-9650331]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061036 |
plasma protease C1 inhibitor sequence variant T467P, signal peptide removed form (human)
|
hSERPING1/var:T467P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Thr-467 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Thr-467, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650562]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061104 |
plasma protease C1 inhibitor sequence variant Q484*, signal peptide removed form (human)
|
hSERPING1/var:Q484*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asp-483 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-483." [PRO:DNx, Reactome:R-HSA-9650410]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061229 |
plasma protease C1 inhibitor sequence variant G493R, signal peptide removed form (human)
|
hSERPING1/var:G493R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-493, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650561]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061277 |
plasma protease C1 inhibitor sequence variant L481R, signal peptide removed form (human)
|
hSERPING1/var:L481R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-481, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9651451]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061318 |
plasma protease C1 inhibitor sequence variant A458V, signal peptide removed form (human)
|
hSERPING1/var:A458V/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Val residue at the position equivalent to Ala-458 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-458, CHEBI:30015." [PRO:DNx, Reactome:R-HSA-9650402]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061510 |
plasma protease C1 inhibitor sequence variant I196N, signal peptide removed form (human)
|
hSERPING1/var:I196N/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Asn residue at the position equivalent to Ile-196 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ile-196, CHEBI:50347." [PRO:DNx, Reactome:R-HSA-9651390]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061553 |
plasma protease C1 inhibitor sequence variant Y496*, signal peptide removed form (human)
|
hSERPING1/var:Y496*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Val-495 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-495." [PRO:DNx, Reactome:R-HSA-9650355]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061573 |
plasma protease C1 inhibitor sequence variant N291H, signal peptide removed form (human)
|
hSERPING1/var:N291H/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a His residue at the position equivalent to Asn-291 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Asn-291, CHEBI:29979." [PRO:DNx, Reactome:R-HSA-9650545]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061585 |
plasma protease C1 inhibitor sequence variant P476L, signal peptide removed form (human)
|
hSERPING1/var:P476L/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Leu residue at the position equivalent to Pro-476 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-476, CHEBI:30006." [PRO:DNx, Reactome:R-HSA-9650563]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061662 |
plasma protease C1 inhibitor sequence variant G184R, signal peptide removed form (human)
|
hSERPING1/var:G184R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-184 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-184, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650424]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061680 |
plasma protease C1 inhibitor sequence variant P498R, signal peptide removed form (human)
|
hSERPING1/var:P498R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Pro-498 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-498, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650544]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061855 |
plasma protease C1 inhibitor sequence variant F236S, signal peptide removed form (human)
|
hSERPING1/var:F236S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Phe-236 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Phe-236, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650538]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000061929 |
plasma protease C1 inhibitor sequence variant R466C, signal peptide removed form (human)
|
hSERPING1/var:R466C/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Cys residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29950." [PRO:DNx, Reactome:R-HSA-9650553]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062268 |
plasma protease C1 inhibitor sequence variant R466S, signal peptide removed form (human)
|
hSERPING1/var:R466S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650572]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062279 |
plasma protease C1 inhibitor sequence variant A458T, signal peptide removed form (human)
|
hSERPING1/var:A458T/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Thr residue at the position equivalent to Ala-458 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ala-458, CHEBI:30013." [PRO:DNx, Reactome:R-HSA-9650554]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062324 |
plasma protease C1 inhibitor sequence variant W482*, signal peptide removed form (human)
|
hSERPING1/var:W482*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-481." [PRO:DNx, Reactome:R-HSA-9650502]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062491 |
plasma protease C1 inhibitor sequence variant P498S, signal peptide removed form (human)
|
hSERPING1/var:P498S/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Ser residue at the position equivalent to Pro-498 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-498, CHEBI:29999." [PRO:DNx, Reactome:R-HSA-9650568]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062550 |
plasma protease C1 inhibitor sequence variant G345R, signal peptide removed form (human)
|
hSERPING1/var:G345R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Gly-345 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-345, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9651385]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062579 |
plasma protease C1 inhibitor sequence variant R494*, signal peptide removed form (human)
|
hSERPING1/var:R494*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-493." [PRO:DNx, Reactome:R-HSA-9650555]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062615 |
plasma protease C1 inhibitor sequence variant Q474*, signal peptide removed form (human)
|
hSERPING1/var:Q474*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Val-473 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-473." [PRO:DNx, Reactome:R-HSA-9650547]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000062857 |
plasma protease C1 inhibitor sequence variant L481P, signal peptide removed form (human)
|
hSERPING1/var:L481P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Leu-481 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Leu-481, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9651448]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063441 |
plasma protease C1 inhibitor sequence variant P489R, signal peptide removed form (human)
|
hSERPING1/var:P489R/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Arg residue at the position equivalent to Pro-489 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Pro-489, CHEBI:29952." [PRO:DNx, Reactome:R-HSA-9650330]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063530 |
plasma protease C1 inhibitor sequence variant R400C, signal peptide removed form (human)
|
hSERPING1/var:R400C/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Cys residue at the position equivalent to Arg-400 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-400, CHEBI:29950." [PRO:DNx, Reactome:R-HSA-9650511]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063553 |
plasma protease C1 inhibitor sequence variant S318*, signal peptide removed form (human)
|
hSERPING1/var:S318*/SigPep-
|
"A plasma protease C1 inhibitor (human) that has has been truncated after the position equivalent to Asn-317 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-317." [PRO:DNx, Reactome:R-HSA-9651387]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063798 |
plasma protease C1 inhibitor sequence variant T189N, signal peptide removed form (human)
|
hSERPING1/var:T189N/SigPep-
|
"A plasma protease C1 inhibitor (human) that has an Asn residue at the position equivalent to Thr-189 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Thr-189, CHEBI:50347." [PRO:DNx, Reactome:R-HSA-9650346]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000063908 |
plasma protease C1 inhibitor sequence variant S170P, signal peptide removed form (human)
|
hSERPING1/var:S170P/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Pro residue at the position equivalent to Ser-170 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Ser-170, CHEBI:50342." [PRO:DNx, Reactome:R-HSA-9650362]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064158 |
plasma protease C1 inhibitor sequence variant G493E, signal peptide removed form (human)
|
hSERPING1/var:G493E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Gly-493 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-493, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650548]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064313 |
plasma protease C1 inhibitor sequence variant G184E, signal peptide removed form (human)
|
hSERPING1/var:G184E/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Glu residue at the position equivalent to Gly-184 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Gly-184, CHEBI:29972." [PRO:DNx, Reactome:R-HSA-9650527]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064435 |
plasma protease C1 inhibitor sequence variant R466H, signal peptide removed form (human)
|
hSERPING1/var:R466H/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a His residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:29979." [PRO:DNx, Reactome:R-HSA-9650560]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000064491 |
plasma protease C1 inhibitor sequence variant R466L, signal peptide removed form (human)
|
hSERPING1/var:R466L/SigPep-
|
"A plasma protease C1 inhibitor (human) that has a Leu residue at the position equivalent to Arg-466 of the amino acid sequence represented by UniProtKB:P05155-1 and that has had the signal peptide removed. Example: UniProtKB:P05155-1, 23-500, Arg-466, CHEBI:30006." [PRO:DNx, Reactome:R-HSA-9650436]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014708 |
serpin H1
|
SERPINH1
|
"A serpin that is a translation product of the human SERPINH1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P13731 |
serpin H1 (chicken)
|
chick-SERPINH1
|
"A serpin H1 that is encoded in the genome of chicken." [OMA:P13731, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P19324 |
serpin H1 (mouse)
|
mSERPINH1
|
"A serpin H1 that is encoded in the genome of mouse." [OMA:P19324, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P19324-1 |
serpin H1 isoform 1 (mouse)
|
mSERPINH1/iso:1
|
"A serpin H1 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000036340 |
serpin H1 acetylated 1 (mouse)
|
mSERPINH1/Ac:1
|
"A serpin H1 that is N-terminal Met acetylated in mouse. UniProtKB:P19324, Met-1, MOD:00058." [TDR:9011]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P29457 |
serpin H1 (rat)
|
rSERPINH1
|
"A serpin H1 that is encoded in the genome of rat." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P29457-1 |
serpin H1 isoform 1 (rat)
|
rSERPINH1/iso:1
|
"A serpin H1 isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P50454 |
serpin H1 (human)
|
hSERPINH1
|
"A serpin H1 that is encoded in the genome of human." [PRO:CNA, UniProtKB:P50454]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049211 |
serpin H1, signal peptide removed form (human)
|
hSERPINH1/SigPep-
|
"A serpin H1 (human) that has had the signal peptide removed. UniProtKB:P50454, 19-418." [PRO:DNx, Reactome:R-HSA-2127480]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056604 |
serpin H1 N-glycosylated 1 (human)
|
hSERPINH1/NGlyco:1
|
"A serpin H1 (human) that has been N-glycosylated at the residue equivalent to Asn-120 of the amino acid sequence represented by UniProtKB:P50454-1, in which the glycan composition is represented by GlyTouCan:G31852PQ. Example: UniProtKB:P50454-1, Asn-120, MOD:00160~GNO:G31852PQ." [GlyGen:P50454-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056605 |
serpin H1 N-glycosylated 2 (human)
|
hSERPINH1/NGlyco:2
|
"A serpin H1 (human) that has been N-glycosylated at the residue equivalent to Asn-120 of the amino acid sequence represented by UniProtKB:P50454-1, in which the glycan composition is represented by GlyTouCan:G41247ZX. Example: UniProtKB:P50454-1, Asn-120, MOD:00160~GNO:G41247ZX." [GlyGen:P50454-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056606 |
serpin H1 N-glycosylated 3 (human)
|
hSERPINH1/NGlyco:3
|
"A serpin H1 (human) that has been N-glycosylated at the residue equivalent to Asn-120 of the amino acid sequence represented by UniProtKB:P50454-1, in which the glycan composition is represented by GlyTouCan:G62765YT. Example: UniProtKB:P50454-1, Asn-120, MOD:00160~GNO:G62765YT." [GlyGen:P50454-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056607 |
serpin H1 N-glycosylated 4 (human)
|
hSERPINH1/NGlyco:4
|
"A serpin H1 (human) that has been N-glycosylated at the residue equivalent to Asn-120 of the amino acid sequence represented by UniProtKB:P50454-1, in which the glycan composition is represented by GlyTouCan:G80920RR. Example: UniProtKB:P50454-1, Asn-120, MOD:00160~GNO:G80920RR." [GlyGen:P50454-1, PMID:23345538, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056608 |
serpin H1 N-glycosylated 5 (human)
|
hSERPINH1/NGlyco:5
|
"A serpin H1 (human) that has been N-glycosylated at the residue equivalent to Asn-125 of the amino acid sequence represented by UniProtKB:P50454-1, in which the glycan composition is represented by GlyTouCan:G31852PQ. Example: UniProtKB:P50454-1, Asn-125, MOD:00160~GNO:G31852PQ." [GlyGen:P50454-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000056609 |
serpin H1 N-glycosylated 6 (human)
|
hSERPINH1/NGlyco:6
|
"A serpin H1 (human) that has been N-glycosylated at the residue equivalent to Asn-125 of the amino acid sequence represented by UniProtKB:P50454-1, in which the glycan composition is represented by GlyTouCan:G62765YT. Example: UniProtKB:P50454-1, Asn-125, MOD:00160~GNO:G62765YT." [GlyGen:P50454-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000069946 |
serpin H1 deaminated 1 (human)
|
hSERPINH1/Deam:1
|
"A serpin H1 (human) that has been deaminated on the residue at the position equivalent to Gln-62 of the amino acid sequence represented by UniProtKB:P50454. UniProtKB:P50454, Gln-62, MOD:00685." [IEDB_epitope:2141471, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000039010 |
serpin H1 isoform 1
|
SERPINH1/iso:1
|
"A serpin H1 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P19324-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P19324-1 |
serpin H1 isoform 1 (mouse)
|
mSERPINH1/iso:1
|
"A serpin H1 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P29457-1 |
serpin H1 isoform 1 (rat)
|
rSERPINH1/iso:1
|
"A serpin H1 isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000021444 |
serpin H1, signal peptide removed form
|
SERPINH1/SigPep-
|
"A serpin H1 that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000049211 |
serpin H1, signal peptide removed form (human)
|
hSERPINH1/SigPep-
|
"A serpin H1 (human) that has had the signal peptide removed. UniProtKB:P50454, 19-418." [PRO:DNx, Reactome:R-HSA-2127480]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014709 |
neuroserpin
|
SERPINI1
|
"A serpin that is a translation product of the human SERPINI1 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:O35684 |
neuroserpin (mouse)
|
mSERPINI1
|
"A neuroserpin that is encoded in the genome of mouse." [OMA:O35684, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O35684-1 |
neuroserpin isoform 1 (mouse)
|
mSERPINI1/iso:1
|
"A neuroserpin isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q90935 |
neuroserpin (chicken)
|
chick-SERPINI1
|
"A neuroserpin that is encoded in the genome of chicken." [OMA:Q90935, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q90935-1 |
neuroserpin isoform 1 (chicken)
|
chick-SERPINI1/iso:1
|
"A neuroserpin isoform 1 that is encoded in the genome of chicken." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q99574 |
neuroserpin (human)
|
hSERPINI1
|
"A neuroserpin that is encoded in the genome of human." [PRO:CNA, UniProtKB:Q99574]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q99574-1 |
neuroserpin isoform 1 (human)
|
hSERPINI1/iso:1
|
"A neuroserpin isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000066495 |
neuroserpin deaminated 1 (human)
|
hSERPINI1/Deam:1
|
"A neuroserpin (human) that has been deaminated on the residue at the position equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:Q99574. UniProtKB:Q99574, Asn-152, MOD:00684." [IEDB_epitope:1762259, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-modification
|
|
PR:000080761 |
neuroserpin deaminated 2 (human)
|
hSERPINI1/Deam:2
|
"A neuroserpin (human) that has been deaminated on the residue at the position equivalent to Gln-103 of the amino acid sequence represented by UniProtKB:Q99574. UniProtKB:Q99574, Gln-103, MOD:00685." [IEDB_epitope:1814086, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9JLD2 |
neuroserpin (rat)
|
rSERPINI1
|
"A neuroserpin that is encoded in the genome of rat." [OMA:Q9JLD2, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q9JLD2-1 |
neuroserpin isoform 1 (rat)
|
rSERPINI1/iso:1
|
"A neuroserpin isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9M1T7 |
serpin-Z4 (Arabidopsis thaliana)
|
At-SERPINI1
|
"A neuroserpin that is encoded in the genome of Arabidopsis thaliana." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000042715 |
neuroserpin isoform 1
|
SERPINI1/iso:1
|
"A neuroserpin that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99574-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O35684-1 |
neuroserpin isoform 1 (mouse)
|
mSERPINI1/iso:1
|
"A neuroserpin isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q90935-1 |
neuroserpin isoform 1 (chicken)
|
chick-SERPINI1/iso:1
|
"A neuroserpin isoform 1 that is encoded in the genome of chicken." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q99574-1 |
neuroserpin isoform 1 (human)
|
hSERPINI1/iso:1
|
"A neuroserpin isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q9JLD2-1 |
neuroserpin isoform 1 (rat)
|
rSERPINI1/iso:1
|
"A neuroserpin isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000014710 |
serpin I2
|
SERPINI2
|
"A serpin that is a translation product of the human SERPINI2 gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:O75830 |
serpin I2 (human)
|
hSERPINI2
|
"A serpin I2 that is encoded in the genome of human." [PRO:CNA, UniProtKB:O75830]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O75830-1 |
serpin I2 isoform 1 (human)
|
hSERPINI2/iso:1
|
"A serpin I2 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:Q9JK88 |
serpin I2 (mouse)
|
mSERPINI2
|
"A serpin I2 that is encoded in the genome of mouse." [OMA:Q9JK88, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q9JK88-1 |
serpin I2 isoform 1 (mouse)
|
mSERPINI2/iso:1
|
"A serpin I2 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000038393 |
serpin I2 isoform 1
|
SERPINI2/iso:1
|
"A serpin I2 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75830-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O75830-1 |
serpin I2 isoform 1 (human)
|
hSERPINI2/iso:1
|
"A serpin I2 isoform 1 that is encoded in the genome of human." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:Q9JK88-1 |
serpin I2 isoform 1 (mouse)
|
mSERPINI2/iso:1
|
"A serpin I2 isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000015927 |
alpha-1-antitrypsin 1-1
|
Serpina1a
|
"A serpin that is a translation product of the mouse Serpina1a gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P07758 |
alpha-1-antitrypsin 1-1 (mouse)
|
mSerpina1a
|
"An alpha-1-antitrypsin 1-1 that is encoded in the genome of mouse." [PRO:CNA, UniProtKB:P07758]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000015928 |
alpha-1-antitrypsin 1-2
|
Serpina1b
|
"A serpin that is a translation product of the mouse Serpina1b gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P22599 |
alpha-1-antitrypsin 1-2 (mouse)
|
mSerpina1b
|
"An alpha-1-antitrypsin 1-2 that is encoded in the genome of mouse." [PRO:CNA, UniProtKB:P22599]
|
|
|
|
|
|
|
| | | | |
| | | | | | | | |
gene
|
|
PR:000025876 |
ovalbumin
|
SERPINB14
|
"A serpin that is a translation product of the chicken SERPINB14 gene or a 1:1 ortholog thereof. Ovalbumin is a storage protein of egg white." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:O73860 |
ovalbumin (turkey)
|
turkey-SERPINB14
|
"An ovalbumin that is encoded in the genome of turkey." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O73860-1 |
ovalbumin isoform 1 (turkey)
|
turkey-SERPINB14/iso:1
|
"An ovalbumin isoform 1 that is encoded in the genome of turkey." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
organism-gene
|
|
PR:P01012 |
ovalbumin (chicken)
|
chick-SERPINB14
|
"An ovalbumin that is encoded in the genome of chicken." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01012-1 |
ovalbumin isoform 1 (chicken)
|
chick-SERPINB14/iso:1
|
"An ovalbumin isoform 1 that is encoded in the genome of chicken." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000025878 |
ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated 1 (chicken)
|
chick-SERPINB14/iso:1/InitMet-/AcNGlycoPhos:1
|
"An ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated precursor that is produced in chicken with the phosphorylation at residues Ser-69 and Ser-345, and the N-glycosylation at residue Asn-293 of the amino acid sequence represented by UniProtKB:P01012-1. UniProtKB:P01012-1, 2-386, Gly-2, MOD:02078|Ser-69/Ser-345, MOD:00046|Asn-293, MOD:00160." [OCA:JP, PMID:1942038]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
sequence
|
|
PR:000025877 |
ovalbumin isoform 1
|
SERPINB14/iso:1
|
"An ovalbumin that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01012-1 or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:O73860-1 |
ovalbumin isoform 1 (turkey)
|
turkey-SERPINB14/iso:1
|
"An ovalbumin isoform 1 that is encoded in the genome of turkey." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
organism-sequence
|
|
PR:P01012-1 |
ovalbumin isoform 1 (chicken)
|
chick-SERPINB14/iso:1
|
"An ovalbumin isoform 1 that is encoded in the genome of chicken." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000025878 |
ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated 1 (chicken)
|
chick-SERPINB14/iso:1/InitMet-/AcNGlycoPhos:1
|
"An ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated precursor that is produced in chicken with the phosphorylation at residues Ser-69 and Ser-345, and the N-glycosylation at residue Asn-293 of the amino acid sequence represented by UniProtKB:P01012-1. UniProtKB:P01012-1, 2-386, Gly-2, MOD:02078|Ser-69/Ser-345, MOD:00046|Asn-293, MOD:00160." [OCA:JP, PMID:1942038]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000025897 |
ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated precursor
|
SERPINB14/iso:1/AcNGlycoPhosRes+
|
"An ovalbumin isoform 1 whose initiator methionine has been removed, followed by N-terminal Gly acetylation, and post-translationally modified to include N-glycosylated and phosphorylated residues." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
organism-modification
|
|
PR:000025878 |
ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated 1 (chicken)
|
chick-SERPINB14/iso:1/InitMet-/AcNGlycoPhos:1
|
"An ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated precursor that is produced in chicken with the phosphorylation at residues Ser-69 and Ser-345, and the N-glycosylation at residue Asn-293 of the amino acid sequence represented by UniProtKB:P01012-1. UniProtKB:P01012-1, 2-386, Gly-2, MOD:02078|Ser-69/Ser-345, MOD:00046|Asn-293, MOD:00160." [OCA:JP, PMID:1942038]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000026568 |
ovalbumin isoform 1, initiator methionine removed form
|
SERPINB14/iso:1/InitMet-
|
"An ovalbumin isoform 1 that has had the initiator methionine removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000025897 |
ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated precursor
|
SERPINB14/iso:1/AcNGlycoPhosRes+
|
"An ovalbumin isoform 1 whose initiator methionine has been removed, followed by N-terminal Gly acetylation, and post-translationally modified to include N-glycosylated and phosphorylated residues." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
organism-modification
|
|
PR:000025878 |
ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated 1 (chicken)
|
chick-SERPINB14/iso:1/InitMet-/AcNGlycoPhos:1
|
"An ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated precursor that is produced in chicken with the phosphorylation at residues Ser-69 and Ser-345, and the N-glycosylation at residue Asn-293 of the amino acid sequence represented by UniProtKB:P01012-1. UniProtKB:P01012-1, 2-386, Gly-2, MOD:02078|Ser-69/Ser-345, MOD:00046|Asn-293, MOD:00160." [OCA:JP, PMID:1942038]
|
|
|
|
|
|
|
| | | | | | |
| | | | | | |
modification
|
|
PR:000026567 |
ovalbumin, initiator methionine removed form
|
SERPINB14/InitMet-
|
"An ovalbumin that has had the initiator methionine removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | | |
modification
|
|
PR:000026568 |
ovalbumin isoform 1, initiator methionine removed form
|
SERPINB14/iso:1/InitMet-
|
"An ovalbumin isoform 1 that has had the initiator methionine removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | | | |
| | |
modification
|
|
PR:000025897 |
ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated precursor
|
SERPINB14/iso:1/AcNGlycoPhosRes+
|
"An ovalbumin isoform 1 whose initiator methionine has been removed, followed by N-terminal Gly acetylation, and post-translationally modified to include N-glycosylated and phosphorylated residues." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
|
organism-modification
|
|
PR:000025878 |
ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated 1 (chicken)
|
chick-SERPINB14/iso:1/InitMet-/AcNGlycoPhos:1
|
"An ovalbumin isoform 1 N-glycosylated, acetylated, and phosphorylated precursor that is produced in chicken with the phosphorylation at residues Ser-69 and Ser-345, and the N-glycosylation at residue Asn-293 of the amino acid sequence represented by UniProtKB:P01012-1. UniProtKB:P01012-1, 2-386, Gly-2, MOD:02078|Ser-69/Ser-345, MOD:00046|Asn-293, MOD:00160." [OCA:JP, PMID:1942038]
|
|
|
|
|
